SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'FLC'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AV2_C_DVAC6_0 (GRAMICIDIN A) |
4bj4 | AMPDH2 (Pseudomonasaeruginosa) | 3 / 3 | ALA A 87VAL A 89TRP A 97 | NoneNoneFLC A1260 (-4.9A) | 0.79A | 1av2C-4bj4A:undetectable1av2D-4bj4A:undetectable | 1av2C-4bj4A:7.481av2D-4bj4A:7.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1BDW_B_DVAB6_0 (GRAMICIDIN A) |
5d55 | HDAB,HDAA (ADHESIN),HUS-ASSOCIATEDDIFFUSE ADHERENCE (Escherichiacoli) | 3 / 3 | TRP A 38ALA A 41VAL A 113 | FLC A 201 (-3.3A)NoneNone | 0.99A | 1bdwA-5d55A:undetectable1bdwB-5d55A:undetectable | 1bdwA-5d55A:6.371bdwB-5d55A:6.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_A_TRPA81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 1c9sA-1zb7A:undetectable1c9sK-1zb7A:undetectable | 1c9sA-1zb7A:9.281c9sK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_C_TRPC81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.26A | 1c9sB-1zb7A:undetectable1c9sC-1zb7A:undetectable | 1c9sB-1zb7A:9.281c9sC-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_D_TRPD81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.21A | 1c9sC-1zb7A:undetectable1c9sD-1zb7A:undetectable | 1c9sC-1zb7A:9.281c9sD-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_E_TRPE81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 1c9sD-1zb7A:undetectable1c9sE-1zb7A:undetectable | 1c9sD-1zb7A:9.281c9sE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_G_TRPG81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.20A | 1c9sF-1zb7A:undetectable1c9sG-1zb7A:undetectable | 1c9sF-1zb7A:9.281c9sG-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_H_TRPH81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 1c9sG-1zb7A:undetectable1c9sH-1zb7A:undetectable | 1c9sG-1zb7A:9.281c9sH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_I_TRPI81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 1c9sH-1zb7A:undetectable1c9sI-1zb7A:undetectable | 1c9sH-1zb7A:9.281c9sI-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1C9S_K_TRPK81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.25A | 1c9sJ-1zb7A:undetectable1c9sK-1zb7A:undetectable | 1c9sJ-1zb7A:9.281c9sK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DF7_A_MTXA501_2 (DIHYDROFOLATEREDUCTASE) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 3 / 3 | TRP A 374ARG A 388THR A 373 | FLC A 505 (-3.0A)NoneNone | 0.76A | 1df7A-4tx8A:undetectable | 1df7A-4tx8A:14.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DMI_A_BHSA1610_1 (NITRIC OXIDESYNTHASE) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 4 / 8 | SER A 140ARG A 365ALA A 144PHE A 333 | NoneFLC A 742 (-2.9A)NoneNone | 0.94A | 1dmiA-1po0A:0.01dmiB-1po0A:0.0 | 1dmiA-1po0A:20.841dmiB-1po0A:20.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 12 | GLY A 42GLY A 43SER A 111PHE A 236HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)NoneFLC A 402 (-3.7A) | 0.93A | 1dx6A-5yhpA:12.7 | 1dx6A-5yhpA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1DX6_A_GNTA602_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 12 | GLY A 113GLY A 42GLY A 43SER A 111HIS A 297 | NoneFLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)FLC A 402 (-3.7A) | 1.00A | 1dx6A-5yhpA:12.7 | 1dx6A-5yhpA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E9Y_B_HAEB800_1 (UREASE SUBUNIT BETA) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 4 / 5 | HIS A 61HIS A 180HIS A 232ASP A 305 | ZN A 423 (-3.5A)FLC A 424 (-4.0A)FLC A 424 (-4.8A)FLC A 424 ( 2.7A) | 0.52A | 1e9yB-3d6nA:22.0 | 1e9yB-3d6nA:22.07 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1E9Y_B_HAEB800_1 (UREASE SUBUNIT BETA) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 5 / 5 | HIS A 58HIS A 62HIS A 80HIS A 104ASP A 161 | FE A 202 (-3.3A)FLC A 203 (-4.0A) FE A 201 ( 3.4A) FE A 201 ( 3.4A) FE A 202 ( 2.5A) | 0.89A | 1e9yB-4n6wA:undetectable | 1e9yB-4n6wA:20.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EE2_B_CHDB1250_1 (ALCOHOLDEHYDROGENASE) |
2p4q | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING 1 (Saccharomycescerevisiae) | 5 / 11 | CYH A 365SER A 139HIS A 185LEU A 352ILE A 357 | NoneNoneFLC A 502 (-4.5A)NoneNone | 1.19A | 1ee2B-2p4qA:2.7 | 1ee2B-2p4qA:21.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ESW_A_ACRA652_1 (AMYLOMALTASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 4 / 6 | GLY A 86ASP A 85GLY A 99SER A 34 | FLC A 300 ( 4.5A)NoneFLC A 300 (-3.8A)FLC A 300 (-2.7A) | 0.99A | 1eswA-4x84A:undetectable | 1eswA-4x84A:18.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1F5L_A_AMRA301_1 (UROKINASE-TYPEPLASMINOGENACTIVATOR) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | GLN A 72GLY A 144CYH A 421GLY A 392 | FLC A 756 (-3.6A)NoneSF4 A 755 (-2.3A)None | 0.70A | 1f5lA-1b0kA:undetectable | 1f5lA-1b0kA:17.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FWE_C_HAEC989_1 (UREASE) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 6 | HIS A 61HIS A 63HIS A 180HIS A 232ASP A 305 | ZN A 423 (-3.5A) ZN A 423 ( 3.4A)FLC A 424 (-4.0A)FLC A 424 (-4.8A)FLC A 424 ( 2.7A) | 0.46A | 1fweC-3d6nA:23.1 | 1fweC-3d6nA:23.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1FWE_C_HAEC989_1 (UREASE) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 5 / 6 | HIS A 58HIS A 62HIS A 80HIS A 104ASP A 161 | FE A 202 (-3.3A)FLC A 203 (-4.0A) FE A 201 ( 3.4A) FE A 201 ( 3.4A) FE A 202 ( 2.5A) | 0.98A | 1fweC-4n6wA:undetectable | 1fweC-4n6wA:17.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_A_TRPA81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 1gtfA-1zb7A:undetectable1gtfK-1zb7A:undetectable | 1gtfA-1zb7A:9.281gtfK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_C_TRPC81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 1gtfB-1zb7A:undetectable1gtfC-1zb7A:undetectable | 1gtfB-1zb7A:9.281gtfC-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_D_TRPD81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.27A | 1gtfC-1zb7A:undetectable1gtfD-1zb7A:undetectable | 1gtfC-1zb7A:9.281gtfD-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_F_TRPF81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 1gtfE-1zb7A:undetectable1gtfF-1zb7A:undetectable | 1gtfE-1zb7A:9.281gtfF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_H_TRPH81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 1gtfG-1zb7A:undetectable1gtfH-1zb7A:undetectable | 1gtfG-1zb7A:9.281gtfH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_J_TRPJ81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.27A | 1gtfI-1zb7A:undetectable1gtfJ-1zb7A:undetectable | 1gtfI-1zb7A:9.281gtfJ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_N_TRPN81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | HIS A 147HIS A 167THR A 168SER A 643 | None O A1100 ( 3.9A)NoneFLC A 756 (-2.8A) | 0.83A | 1gtfN-1b0kA:undetectable1gtfO-1b0kA:undetectable | 1gtfN-1b0kA:8.161gtfO-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_P_TRPP81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 1gtfP-1zb7A:undetectable1gtfQ-1zb7A:undetectable | 1gtfP-1zb7A:9.281gtfQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_T_TRPT81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 1gtfT-1zb7A:undetectable1gtfU-1zb7A:undetectable | 1gtfT-1zb7A:9.281gtfU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_U_TRPU81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 1gtfU-1zb7A:undetectable1gtfV-1zb7A:undetectable | 1gtfU-1zb7A:9.281gtfV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTF_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN(TRAP)) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.20A | 1gtfL-1zb7A:undetectable1gtfV-1zb7A:undetectable | 1gtfL-1zb7A:9.281gtfV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_H_TRPH81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.26A | 1gtnG-1zb7A:undetectable1gtnH-1zb7A:undetectable | 1gtnG-1zb7A:9.281gtnH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_M_TRPM81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 1gtnM-1zb7A:undetectable1gtnN-1zb7A:undetectable | 1gtnM-1zb7A:9.281gtnN-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_N_TRPN81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 1gtnN-1zb7A:undetectable1gtnO-1zb7A:undetectable | 1gtnN-1zb7A:9.281gtnO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_P_TRPP81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 8 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 1gtnP-1zb7A:undetectable1gtnQ-1zb7A:undetectable | 1gtnP-1zb7A:9.281gtnQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1GTN_V_TRPV81_0 (TRP RNA-BINDINGATTENUATION PROTEIN) |
5z72 | CCPC (Bacillusvelezensis) | 5 / 12 | GLY A 148THR A 262SER A 129ALA A 98ILE A 218 | NoneNoneFLC A 303 ( 2.1A)FLC A 303 (-3.1A)FLC A 303 ( 4.5A) | 0.98A | 1gtnL-5z72A:undetectable1gtnV-5z72A:undetectable | 1gtnL-5z72A:undetectable1gtnV-5z72A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_A_ADNA1260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.31A | 1jdvA-5cyfA:23.51jdvD-5cyfA:23.5 | 1jdvA-5cyfA:25.581jdvD-5cyfA:25.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_B_ADNB2260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.31A | 1jdvB-5cyfA:23.61jdvC-5cyfA:6.5 | 1jdvB-5cyfA:25.581jdvC-5cyfA:25.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_D_ADND3260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.30A | 1jdvA-5cyfA:23.51jdvD-5cyfA:23.5 | 1jdvA-5cyfA:25.581jdvD-5cyfA:25.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JDV_E_ADNE4260_1 (5'-METHYLTHIOADENOSINE PHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 12 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.32A | 1jdvE-5cyfA:23.51jdvF-5cyfA:24.1 | 1jdvE-5cyfA:25.581jdvF-5cyfA:25.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JLF_A_NVPA999_1 (HIV-1 RT A-CHAINHIV-1 RT B-CHAIN) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 4 / 8 | GLY A 175TRP A 383TYR A 474GLU A 417 | NoneNoneNoneFLC A 743 ( 4.8A) | 1.08A | 1jlfA-1po0A:undetectable1jlfB-1po0A:undetectable | 1jlfA-1po0A:22.381jlfB-1po0A:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2R_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 1k2rA-4lmvA:undetectable1k2rB-4lmvA:undetectable | 1k2rA-4lmvA:21.101k2rB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2S_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 1k2sA-4lmvA:undetectable1k2sB-4lmvA:undetectable | 1k2sA-4lmvA:21.101k2sB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K2U_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.07A | 1k2uA-4lmvA:undetectable1k2uB-4lmvA:undetectable | 1k2uA-4lmvA:21.101k2uB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LZX_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 1lzxA-4lmvA:undetectable1lzxB-4lmvA:undetectable | 1lzxA-4lmvA:21.101lzxB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LZX_B_H4BB1760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 1lzxA-4lmvA:undetectable1lzxB-4lmvA:undetectable | 1lzxA-4lmvA:21.101lzxB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1LZZ_B_H4BB1760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 1lzzA-4lmvA:undetectable1lzzB-4lmvA:undetectable | 1lzzA-4lmvA:21.101lzzB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MMV_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.07A | 1mmvA-4lmvA:undetectable1mmvB-4lmvA:undetectable | 1mmvA-4lmvA:21.101mmvB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MMW_A_H4BA1760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 1mmwA-4lmvA:undetectable1mmwB-4lmvA:undetectable | 1mmwA-4lmvA:21.101mmwB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MMW_B_H4BB2760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 1mmwA-4lmvA:undetectable1mmwB-4lmvA:undetectable | 1mmwA-4lmvA:21.101mmwB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MUO_A_ADNA1_1 (AURORA-RELATEDKINASE 1) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 9 | GLY A 215VAL A 222ALA A 233LEU A 263TYR A 285LEU A 343 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 ( 4.6A)TAK A1507 (-4.7A) | 0.88A | 1muoA-4c02A:7.8 | 1muoA-4c02A:26.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MXD_A_ACRA732_1 (ALPHA AMYLASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 5 / 9 | GLY A 430GLY A 183GLY A 404GLY A 406ASP A 407 | NoneNoneFLC A 501 (-3.6A)NoneNone | 1.04A | 1mxdA-5x9rA:undetectable | 1mxdA-5x9rA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MXG_A_ACRA442_1 (ALPHA AMYLASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 5 / 11 | GLY A 430GLY A 183GLY A 404GLY A 406ASP A 407 | NoneNoneFLC A 501 (-3.6A)NoneNone | 1.04A | 1mxgA-5x9rA:undetectable | 1mxgA-5x9rA:20.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MXG_A_ACRA443_1 (ALPHA AMYLASE) |
4x4w | CCA TRNANUCLEOTIDYLTRANSFERASE 1, MITOCHONDRIAL (Homosapiens) | 4 / 8 | THR A 128ASN A 130ASP A 126GLU A 215 | NoneFLC A 501 ( 3.6A)FLC A 501 ( 4.7A)FLC A 501 ( 4.8A) | 1.08A | 1mxgA-4x4wA:undetectable | 1mxgA-4x4wA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NBI_A_SAMA293_1 (GLYCINEN-METHYLTRANSFERASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 4 / 5 | ARG A 428ASP A 112ASN A 109TYR A 300 | FLC A 501 (-2.8A)NoneNoneNone | 1.21A | 1nbiA-5x9rA:undetectable | 1nbiA-5x9rA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NBI_B_SAMB1293_1 (GLYCINEN-METHYLTRANSFERASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 4 / 5 | ARG A 428ASP A 112ASN A 109TYR A 300 | FLC A 501 (-2.8A)NoneNoneNone | 1.21A | 1nbiB-5x9rA:undetectable | 1nbiB-5x9rA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NW5_A_SAMA401_1 (MODIFICATIONMETHYLASE RSRI) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 3 / 3 | ASP A 348HIS A 288ASP A 155 | FLC A 509 ( 4.8A) ZN A 508 (-3.1A)None | 0.67A | 1nw5A-5hvfA:undetectable | 1nw5A-5hvfA:19.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_A_ADNA1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.33A | 1odiA-5cyfA:23.8 | 1odiA-5cyfA:26.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_B_ADNB1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.36A | 1odiB-5cyfA:23.8 | 1odiB-5cyfA:26.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_C_ADNC1238_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.26A | 1odiC-5cyfA:24.0 | 1odiC-5cyfA:26.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_D_ADND1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.33A | 1odiD-5cyfA:23.9 | 1odiD-5cyfA:26.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_E_ADNE1237_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.28A | 1odiE-5cyfA:23.9 | 1odiE-5cyfA:26.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ODI_F_ADNF1238_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.26A | 1odiF-5cyfA:23.8 | 1odiF-5cyfA:26.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE1_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 3 / 3 | ASP A 257HIS A 290HIS A 231 | FLC A 501 (-3.8A)FLC A 501 (-3.8A)FLC A 501 (-3.9A) | 0.67A | 1oe1A-5jpeA:undetectable | 1oe1A-5jpeA:23.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OE3_A_CUA502_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 3 / 3 | ASP A 257HIS A 290HIS A 231 | FLC A 501 (-3.8A)FLC A 501 (-3.8A)FLC A 501 (-3.9A) | 0.66A | 1oe3A-5jpeA:undetectable | 1oe3A-5jpeA:23.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ONI_A_BEZA501_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
3mqw | PUTATIVEENDORIBONUCLEASEL-PSP (Entamoebahistolytica) | 4 / 7 | TYR A 19ILE A 35PRO A 114GLU A 120 | FLC A 140 (-4.0A)FLC A 140 (-4.8A)FLC A 140 (-4.5A)FLC A 140 (-2.8A) | 0.43A | 1oniA-3mqwA:23.01oniB-3mqwA:22.8 | 1oniA-3mqwA:42.751oniB-3mqwA:42.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ONI_B_BEZB503_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
3mqw | PUTATIVEENDORIBONUCLEASEL-PSP (Entamoebahistolytica) | 4 / 6 | TYR A 19ILE A 35PRO A 114GLU A 120 | FLC A 140 (-4.0A)FLC A 140 (-4.8A)FLC A 140 (-4.5A)FLC A 140 (-2.8A) | 0.41A | 1oniB-3mqwA:22.81oniC-3mqwA:22.8 | 1oniB-3mqwA:42.751oniC-3mqwA:42.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ONI_C_BEZC505_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
3mqw | PUTATIVEENDORIBONUCLEASEL-PSP (Entamoebahistolytica) | 4 / 6 | TYR A 19ILE A 35PRO A 114GLU A 120 | FLC A 140 (-4.0A)FLC A 140 (-4.8A)FLC A 140 (-4.5A)FLC A 140 (-2.8A) | 0.32A | 1oniA-3mqwA:23.01oniC-3mqwA:22.8 | 1oniA-3mqwA:42.751oniC-3mqwA:42.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ONI_E_BEZE509_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
3mqw | PUTATIVEENDORIBONUCLEASEL-PSP (Entamoebahistolytica) | 4 / 7 | TYR A 19ILE A 35PRO A 114GLU A 120 | FLC A 140 (-4.0A)FLC A 140 (-4.8A)FLC A 140 (-4.5A)FLC A 140 (-2.8A) | 0.42A | 1oniD-3mqwA:23.01oniE-3mqwA:22.9 | 1oniD-3mqwA:42.751oniE-3mqwA:42.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1ONI_I_BEZI517_0 (14.5 KDATRANSLATIONALINHIBITOR PROTEIN) |
3mqw | PUTATIVEENDORIBONUCLEASEL-PSP (Entamoebahistolytica) | 4 / 7 | TYR A 19ILE A 35PRO A 114GLU A 120 | FLC A 140 (-4.0A)FLC A 140 (-4.8A)FLC A 140 (-4.5A)FLC A 140 (-2.8A) | 0.46A | 1oniG-3mqwA:22.81oniI-3mqwA:23.0 | 1oniG-3mqwA:42.751oniI-3mqwA:42.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OS2_A_HAEA874_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 5 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.35A | 1os2A-4a3wA:7.9 | 1os2A-4a3wA:26.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1OS2_D_HAED574_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.34A | 1os2D-4a3wA:7.9 | 1os2D-4a3wA:26.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6H_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 1p6hA-4lmvA:undetectable1p6hB-4lmvA:undetectable | 1p6hA-4lmvA:21.001p6hB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6H_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 1p6hA-4lmvA:undetectable1p6hB-4lmvA:undetectable | 1p6hA-4lmvA:21.001p6hB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6I_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.14A | 1p6iA-4lmvA:undetectable1p6iB-4lmvA:undetectable | 1p6iA-4lmvA:21.001p6iB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 1p6kA-4lmvA:undetectable1p6kB-4lmvA:undetectable | 1p6kA-4lmvA:21.001p6kB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1PW7_A_RABA645_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121SER A 125GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)NoneNoneNoneFLC A 301 (-2.8A) | 1.48A | 1pw7A-5cyfA:24.5 | 1pw7A-5cyfA:27.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1QTI_A_GNTA600_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 12 | GLY A 42GLY A 43SER A 111PHE A 236HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)NoneFLC A 402 (-3.7A) | 0.85A | 1qtiA-5yhpA:11.6 | 1qtiA-5yhpA:19.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RJD_A_SAMA801_1 (CARBOXY METHYLTRANSFERASE FORPROTEIN PHOSPHATASE2A CATALYTIC SUBUNIT) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 6 | ARG A 121TYR A 198ASN A 205GLU A 232 | FLC A 301 (-3.0A)NoneNoneNone | 1.32A | 1rjdA-5cyfA:undetectable | 1rjdA-5cyfA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 8 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 1rs6A-4lmvA:undetectable1rs6B-4lmvA:undetectable | 1rs6A-4lmvA:21.001rs6B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_B_URFB2011_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.39A | 1rxcB-5cyfA:26.2 | 1rxcB-5cyfA:25.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_E_URFE2031_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.48A | 1rxcE-5cyfA:26.3 | 1rxcE-5cyfA:25.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_I_URFI2041_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.42A | 1rxcI-5cyfA:26.3 | 1rxcI-5cyfA:25.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RXC_K_URFK2061_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.40A | 1rxcK-5cyfA:24.9 | 1rxcK-5cyfA:25.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S9A_A_BEZA306_0 (CHLOROCATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 7 / 11 | GLY A 106PRO A 107TYR A 160TYR A 194ARG A 215HIS A 218HIS A 220 | FLC A 293 ( 4.3A)FLC A 293 (-3.5A) FE A 292 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A) | 0.36A | 1s9aA-3n9tA:28.2 | 1s9aA-3n9tA:31.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S9A_A_BEZA306_0 (CHLOROCATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 5 / 11 | GLY A 106TYR A 194ARG A 215HIS A 218HIS A 234 | FLC A 293 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A) FE A 292 ( 3.2A)None | 1.45A | 1s9aA-3n9tA:28.2 | 1s9aA-3n9tA:31.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S9A_B_BEZB307_0 (CHLOROCATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 5 / 12 | GLY A 106PRO A 107ARG A 215HIS A 218HIS A 234 | FLC A 293 ( 4.3A)FLC A 293 (-3.5A)FLC A 293 (-4.3A) FE A 292 ( 3.2A)None | 1.42A | 1s9aB-3n9tA:28.0 | 1s9aB-3n9tA:31.56 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1S9A_B_BEZB307_0 (CHLOROCATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 7 / 12 | GLY A 106PRO A 107TYR A 160TYR A 194ARG A 215HIS A 218HIS A 220 | FLC A 293 ( 4.3A)FLC A 293 (-3.5A) FE A 292 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A) | 0.29A | 1s9aB-3n9tA:28.0 | 1s9aB-3n9tA:31.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1S9Q_A_CHDA459_0 (ESTROGEN-RELATEDRECEPTOR GAMMA) |
2q7b | ACETYLTRANSFERASE,GNAT FAMILY (Streptococcusagalactiae) | 4 / 6 | ASP A 118LEU A 117VAL A 116ILE A 115 | FLC A 164 (-3.2A)NoneNoneNone | 0.80A | 1s9qA-2q7bA:undetectable | 1s9qA-2q7bA:22.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_A_BEZA881_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 10 / 11 | ASP A 80GLY A 106PRO A 107TYR A 160TYR A 194ILE A 196ARG A 215HIS A 218HIS A 220VAL A 248 | FLC A 293 (-3.6A)FLC A 293 ( 4.3A)FLC A 293 (-3.5A) FE A 292 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A)FLC A 293 (-4.7A) | 0.49A | 1tmxA-3n9tA:33.0 | 1tmxA-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_A_BEZA881_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 8 / 11 | ASP A 80GLY A 106PRO A 107TYR A 194ILE A 196ARG A 215HIS A 218HIS A 234 | FLC A 293 (-3.6A)FLC A 293 ( 4.3A)FLC A 293 (-3.5A)FLC A 293 ( 4.0A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.2A)None | 1.30A | 1tmxA-3n9tA:33.0 | 1tmxA-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_A_BEZA881_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 6 / 11 | LEU A 77ASP A 80TYR A 160ILE A 196HIS A 218VAL A 248 | FLC A 293 (-4.4A)FLC A 293 (-3.6A) FE A 292 ( 4.3A)FLC A 293 (-4.1A) FE A 292 ( 3.2A)FLC A 293 (-4.7A) | 1.47A | 1tmxA-3n9tA:33.0 | 1tmxA-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_A_BEZA881_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 9 / 11 | LEU A 77ASP A 80TYR A 160TYR A 194ILE A 196ARG A 215HIS A 218HIS A 220VAL A 248 | FLC A 293 (-4.4A)FLC A 293 (-3.6A) FE A 292 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A)FLC A 293 (-4.7A) | 0.52A | 1tmxA-3n9tA:33.0 | 1tmxA-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_A_BEZA881_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 7 / 11 | LEU A 77ASP A 80TYR A 194ILE A 196ARG A 215HIS A 218HIS A 234 | FLC A 293 (-4.4A)FLC A 293 (-3.6A)FLC A 293 ( 4.0A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.2A)None | 1.39A | 1tmxA-3n9tA:33.0 | 1tmxA-3n9tA:44.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TMX_A_BEZA881_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 5 / 11 | LEU A 408ASP A 407GLY A 403ILE A 121HIS A 299 | NoneNoneFLC A 501 ( 3.8A)NoneNone | 1.19A | 1tmxA-5x9rA:undetectable | 1tmxA-5x9rA:20.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_B_BEZB882_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 5 / 12 | ASP A 80GLY A 106TYR A 160HIS A 218HIS A 234 | FLC A 293 (-3.6A)FLC A 293 ( 4.3A) FE A 292 ( 4.3A) FE A 292 ( 3.2A)None | 1.34A | 1tmxB-3n9tA:33.3 | 1tmxB-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_B_BEZB882_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 12 / 12 | LEU A 77ASP A 80GLY A 106PRO A 107TYR A 160TYR A 194ILE A 196ARG A 215HIS A 218HIS A 220HIS A 234VAL A 248 | FLC A 293 (-4.4A)FLC A 293 (-3.6A)FLC A 293 ( 4.3A)FLC A 293 (-3.5A) FE A 292 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A)NoneFLC A 293 (-4.7A) | 0.47A | 1tmxB-3n9tA:33.3 | 1tmxB-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_B_BEZB882_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 9 / 12 | LEU A 77ASP A 80GLY A 106PRO A 107TYR A 194ILE A 196ARG A 215HIS A 218HIS A 234 | FLC A 293 (-4.4A)FLC A 293 (-3.6A)FLC A 293 ( 4.3A)FLC A 293 (-3.5A)FLC A 293 ( 4.0A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.2A)None | 1.21A | 1tmxB-3n9tA:33.3 | 1tmxB-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_B_BEZB882_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 7 / 12 | LEU A 77ASP A 80TYR A 160ILE A 196HIS A 218HIS A 234VAL A 248 | FLC A 293 (-4.4A)FLC A 293 (-3.6A) FE A 292 ( 4.3A)FLC A 293 (-4.1A) FE A 292 ( 3.2A)NoneFLC A 293 (-4.7A) | 1.48A | 1tmxB-3n9tA:33.3 | 1tmxB-3n9tA:44.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1TMX_B_BEZB882_0 (HYDROXYQUINOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 7 / 12 | LEU A 77PRO A 107ILE A 196ARG A 215HIS A 220HIS A 218VAL A 248 | FLC A 293 (-4.4A)FLC A 293 (-3.5A)FLC A 293 (-4.1A)FLC A 293 (-4.3A) FE A 292 ( 3.1A) FE A 292 ( 3.2A)FLC A 293 (-4.7A) | 1.48A | 1tmxB-3n9tA:33.3 | 1tmxB-3n9tA:44.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1TW4_A_CHDA130_1 (FATTY ACID-BINDINGPROTEIN) |
2q7b | ACETYLTRANSFERASE,GNAT FAMILY (Streptococcusagalactiae) | 3 / 3 | TYR A 130ARG A 152GLN A 24 | NoneFLC A 164 (-4.3A)FLC A 164 (-3.9A) | 0.82A | 1tw4A-2q7bA:undetectable | 1tw4A-2q7bA:25.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UDT_A_VIAA1000_1 (CGMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 5 / 12 | ASN A 272ILE A 255VAL A 267LEU A 275MET A 299 | FLC A 504 ( 4.1A)NoneNoneNoneNone | 1.33A | 1udtA-4tx8A:undetectable | 1udtA-4tx8A:19.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_D_TRPD81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 1utdD-1zb7A:undetectable1utdE-1zb7A:undetectable | 1utdD-1zb7A:9.281utdE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_G_TRPG81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.28A | 1utdG-1zb7A:undetectable1utdH-1zb7A:undetectable | 1utdG-1zb7A:9.281utdH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_K_TRPK81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.25A | 1utdA-1zb7A:undetectable1utdK-1zb7A:undetectable | 1utdA-1zb7A:9.281utdK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_L_TRPL81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
5z72 | CCPC (Bacillusvelezensis) | 5 / 12 | ILE A 218GLY A 148THR A 262SER A 129ALA A 98 | FLC A 303 ( 4.5A)NoneNoneFLC A 303 ( 2.1A)FLC A 303 (-3.1A) | 0.95A | 1utdL-5z72A:undetectable1utdM-5z72A:undetectable | 1utdL-5z72A:undetectable1utdM-5z72A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_M_TRPM81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 1utdM-1zb7A:undetectable1utdN-1zb7A:undetectable | 1utdM-1zb7A:9.281utdN-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_N_TRPN81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.25A | 1utdN-1zb7A:undetectable1utdO-1zb7A:undetectable | 1utdN-1zb7A:9.281utdO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_O_TRPO81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
5z72 | CCPC (Bacillusvelezensis) | 5 / 12 | ILE A 218GLY A 148THR A 262SER A 129ALA A 98 | FLC A 303 ( 4.5A)NoneNoneFLC A 303 ( 2.1A)FLC A 303 (-3.1A) | 0.95A | 1utdO-5z72A:undetectable1utdP-5z72A:undetectable | 1utdO-5z72A:undetectable1utdP-5z72A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_P_TRPP81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
5z72 | CCPC (Bacillusvelezensis) | 5 / 11 | ILE A 218GLY A 148THR A 262SER A 129ALA A 98 | FLC A 303 ( 4.5A)NoneNoneFLC A 303 ( 2.1A)FLC A 303 (-3.1A) | 0.94A | 1utdP-5z72A:undetectable1utdQ-5z72A:undetectable | 1utdP-5z72A:undetectable1utdQ-5z72A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_Q_TRPQ81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.10A | 1utdQ-1zb7A:undetectable1utdR-1zb7A:undetectable | 1utdQ-1zb7A:9.281utdR-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTD_R_TRPR81_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 1utdR-1zb7A:undetectable1utdS-1zb7A:undetectable | 1utdR-1zb7A:9.281utdS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTT_A_HAEA1265_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.22A | 1uttA-4a3wA:8.1 | 1uttA-4a3wA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTZ_A_HAEA1267_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.31A | 1utzA-4a3wA:8.0 | 1utzA-4a3wA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UTZ_B_HAEB1266_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.27A | 1utzB-4a3wA:8.2 | 1utzB-4a3wA:25.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_A_BAXA1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | ALA A 233LEU A 263THR A 283LEU A 319HIS A 334 | TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneNone | 0.37A | 1uwhA-4c02A:24.8 | 1uwhA-4c02A:28.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWH_B_BAXB1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | ALA A 233LYS A 235LEU A 263THR A 283LEU A 319HIS A 334 | TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneNone | 0.58A | 1uwhB-4c02A:24.7 | 1uwhB-4c02A:28.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_A_BAXA1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | VAL A 222ALA A 233LEU A 263THR A 283LEU A 319HIS A 334 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneNone | 0.48A | 1uwjA-4c02A:6.9 | 1uwjA-4c02A:27.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UWJ_B_BAXB1723_1 (B-RAF PROTO-ONCOGENESERINE/THREONINE-PROTEIN KINASE) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | VAL A 222ALA A 233LEU A 263THR A 283LEU A 319HIS A 334 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneNone | 0.47A | 1uwjB-4c02A:7.0 | 1uwjB-4c02A:27.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W5U_C_DVAC6_0 (GRAMICIDIN D) |
4bj4 | AMPDH2 (Pseudomonasaeruginosa) | 3 / 3 | ALA A 87VAL A 89TRP A 97 | NoneNoneFLC A1260 (-4.9A) | 0.79A | 1w5uC-4bj4A:undetectable1w5uD-4bj4A:undetectable | 1w5uC-4bj4A:7.481w5uD-4bj4A:7.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W76_A_GNTA1538_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 11 | GLY A 42GLY A 43SER A 111PHE A 228HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)NoneFLC A 402 (-3.7A) | 1.04A | 1w76A-5yhpA:12.0 | 1w76A-5yhpA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W76_B_GNTB1538_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 10 | GLY A 42GLY A 43SER A 111PHE A 236HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)NoneFLC A 402 (-3.7A) | 0.83A | 1w76B-5yhpA:12.1 | 1w76B-5yhpA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WG8_B_SAMB3141_0 (PREDICTEDS-ADENOSYLMETHIONINE-DEPENDENTMETHYLTRANSFERASE) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 5 / 12 | GLY A 312GLY A 313GLY A 724ASP A 720SER A 140 | NoneNoneNoneFLC A 742 (-4.1A)None | 1.11A | 1wg8B-1po0A:undetectable | 1wg8B-1po0A:17.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WOP_A_FFOA2887_1 (AMINOMETHYLTRANSFERASE) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 3 / 3 | ASP B 258GLU B 217ARG B 97 | NoneNoneFLC B 292 (-2.8A) | 0.87A | 1wopA-3d6nB:undetectable | 1wopA-3d6nB:23.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1WRL_D_TFPD205_1 (TROPONIN C, SLOWSKELETAL AND CARDIACMUSCLES) |
4a1f | REPLICATIVE DNAHELICASE (Helicobacterpylori) | 5 / 10 | MET A 234GLU A 256MET A 214MET A 213SER A 211 | FLC A1474 (-4.0A)NoneNoneNoneFLC A1474 (-2.9A) | 1.21A | 1wrlC-4a1fA:undetectable1wrlD-4a1fA:undetectable | 1wrlC-4a1fA:15.221wrlD-4a1fA:15.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1X70_A_715A801_2 (DIPEPTIDYL PEPTIDASEIV) |
2p2w | CITRATE SYNTHASE (Thermotogamaritima) | 3 / 3 | ARG A 325SER A 99TYR A 196 | FLC A 401 ( 3.1A)NoneNone | 0.67A | 1x70A-2p2wA:undetectable | 1x70A-2p2wA:20.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1XOQ_B_ROFB501_1 (CAMP-SPECIFIC3',5'-CYCLICPHOSPHODIESTERASE 4D) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 3 / 3 | MET A 57ASN A 233GLN A 22 | NoneFLC A 302 (-4.2A)None | 1.06A | 1xoqB-4to8A:undetectable | 1xoqB-4to8A:22.41 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Y93_A_HAEA301_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 6 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.32A | 1y93A-4a3wA:8.1 | 1y93A-4a3wA:26.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1YMX_B_CFXB1002_1 (BETA-LACTAMASECTX-M-9) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239GLY A 241SER A 242GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.2A)FLC A 301 (-2.8A)None | 0.74A | 1ymxB-5ctmA:18.8 | 1ymxB-5ctmA:23.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Z35_A_2FAA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.33A | 1z35A-5cyfA:23.5 | 1z35A-5cyfA:26.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1Z37_A_ADNA300_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 9 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.37A | 1z37A-5cyfA:23.5 | 1z37A-5cyfA:26.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZVL_A_H4BA900_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 1zvlA-4lmvA:undetectable1zvlB-4lmvA:undetectable | 1zvlA-4lmvA:21.001zvlB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZQ_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 1zzqA-4lmvA:undetectable1zzqB-4lmvA:undetectable | 1zzqA-4lmvA:21.101zzqB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AC7_A_ADNA1216_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.34A | 2ac7A-5cyfA:22.62ac7B-5cyfA:22.6 | 2ac7A-5cyfA:24.922ac7B-5cyfA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AC7_B_ADNB1215_1 (PURINE NUCLEOSIDEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.35A | 2ac7A-5cyfA:22.62ac7B-5cyfA:22.6 | 2ac7A-5cyfA:24.922ac7B-5cyfA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AQU_B_DR7B300_1 (HIV-1 PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 10 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 0.95A | 2aquA-4x84A:undetectable | 2aquA-4x84A:19.48 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2AXN_A_EDTA737_0 (6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BIPHOSPHATASE 3(6PF-2-K/FRU-2,6-P2ASEBRAIN/PLACENTA-TYPEISOZYME) (IPFK-2)[INCLUDES: 6-PHOSPHOFRUCTO-2-KINASE (EC 2.7.1.105) FRUCTOSE-2,6-BISPHOSPHATASE (EC3.1.3.46)]) |
5htk | 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2 (Homosapiens) | 12 / 12 | PRO A 47LYS A 51THR A 52ASN A 73GLY A 75ARG A 79PHE A 91ARG A 102ALA A 129THR A 130ARG A 193TYR A 197 | ATP A 602 (-4.3A)ATP A 602 (-2.7A)ATP A 602 ( 3.1A)ATP A 602 ( 3.9A)FLC A 601 (-3.0A)ATP A 602 ( 4.1A)FLC A 601 ( 4.8A)GOL A 606 ( 2.0A)FLC A 601 (-3.3A)FLC A 601 (-2.7A)NoneGOL A 606 ( 3.4A) | 0.54A | 2axnA-5htkA:48.1 | 2axnA-5htkA:67.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BJF_A_DXCA330_0 (CHOLOYLGLYCINEHYDROLASE) |
3blw | ISOCITRATEDEHYDROGENASE [NAD]SUBUNIT 1 (Saccharomycescerevisiae) | 5 / 12 | ARG A 274PHE A 230ALA A 108ILE A 214THR A 235 | FLC A1001 (-3.4A)NoneNoneNoneNone | 1.13A | 2bjfA-3blwA:undetectable | 2bjfA-3blwA:25.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BL9_A_CP6A1240_1 (DIHYDROFOLATEREDUCTASE-THYMIDYLATE SYNTHASE) |
5wxu | 11S GLOBULIN (Wrightiatinctoria) | 5 / 12 | ILE A 105ALA A 333LEU A 326ILE A 295ILE A 104 | NoneNoneNoneFLC A 503 (-3.9A)None | 1.11A | 2bl9A-5wxuA:undetectable | 2bl9A-5wxuA:14.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXC_A_P1ZA2001_1 (SERUM ALBUMIN) |
4uzy | FLAGELLAR ASSOCIATEDPROTEIN (Chlamydomonasreinhardtii) | 6 / 12 | SER A 423LEU A 349LEU A 317ALA A 330ILE A 357ALA A 356 | NoneFLC A1647 (-3.9A)NoneNoneNoneNone | 1.13A | 2bxcA-4uzyA:undetectable | 2bxcA-4uzyA:24.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C8A_A_NCAA1252_0 (MONO-ADP-RIBOSYLTRANSFERASE C3) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 7 | SER A 291SER A 289PHE A 372GLU A 363 | NoneNoneNoneFLC A 509 (-3.3A) | 1.22A | 2c8aA-5hvfA:undetectable | 2c8aA-5hvfA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C8A_B_NCAB1246_0 (MONO-ADP-RIBOSYLTRANSFERASE C3) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 5 / 7 | GLY A 371SER A 291SER A 289PHE A 372GLU A 363 | NoneNoneNoneNoneFLC A 509 (-3.3A) | 1.27A | 2c8aB-5hvfA:undetectable | 2c8aB-5hvfA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2C8A_C_NCAC1252_0 (MONO-ADP-RIBOSYLTRANSFERASE C3) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 6 | SER A 291SER A 289PHE A 372GLU A 363 | NoneNoneNoneFLC A 509 (-3.3A) | 1.28A | 2c8aC-5hvfA:undetectable | 2c8aC-5hvfA:20.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2E1Q_D_SALD5006_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 4 / 5 | ARG B 97PHE B 41THR B 48LEU B 50 | FLC B 292 (-2.8A)NoneFLC B 292 (-4.1A)None | 1.37A | 2e1qD-3d6nB:undetectable | 2e1qD-3d6nB:11.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F6D_A_ACRA996_1 (GLUCOAMYLASE GLU1) |
2p2w | CITRATE SYNTHASE (Thermotogamaritima) | 5 / 7 | HIS A 211ASN A 298ASP A 257THR A 318GLY A 212 | FLC A 401 ( 4.5A)FLC A 401 ( 4.0A)NoneNoneFLC A 401 ( 4.0A) | 1.35A | 2f6dA-2p2wA:undetectable | 2f6dA-2p2wA:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6H_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 8 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.13A | 2g6hA-4lmvA:undetectable2g6hB-4lmvA:undetectable | 2g6hA-4lmvA:21.102g6hB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6H_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 2g6hA-4lmvA:undetectable2g6hB-4lmvA:undetectable | 2g6hA-4lmvA:21.102g6hB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6K_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.13A | 2g6kA-4lmvA:undetectable2g6kB-4lmvA:undetectable | 2g6kA-4lmvA:21.102g6kB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6M_A_H4BA760_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 2g6mA-4lmvA:undetectable2g6mB-4lmvA:undetectable | 2g6mA-4lmvA:21.102g6mB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2G6M_B_H4BB761_1 (NITRIC-OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 2g6mA-4lmvA:undetectable2g6mB-4lmvA:undetectable | 2g6mA-4lmvA:21.102g6mB-4lmvA:21.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HMA_A_SAMA375_0 (PROBABLE TRNA(5-METHYLAMINOMETHYL-2-THIOURIDYLATE)-METHYLTRANSFERASE) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 5 / 11 | GLY A 180SER A 643ASP A 100THR A 168HIS A 147 | NoneFLC A 756 (-2.8A)NoneNoneNone | 1.40A | 2hmaA-1b0kA:undetectable | 2hmaA-1b0kA:18.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HS1_A_017A201_1 (HIV-1 PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 12 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 0.99A | 2hs1A-4x84A:undetectable | 2hs1A-4x84A:18.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HU6_A_HAEA269_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.29A | 2hu6A-4a3wA:8.1 | 2hu6A-4a3wA:26.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HX4_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 2hx4A-4lmvA:undetectable2hx4B-4lmvA:undetectable | 2hx4A-4lmvA:21.002hx4B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IGT_A_SAMA1001_0 (SAM DEPENDENTMETHYLTRANSFERASE) |
3aqu | AT4G19810 (Arabidopsisthaliana) | 5 / 12 | TYR A 290ALA A 238PRO A 198GLY A 188GLY A 262 | FLC A 356 (-4.6A)NoneNoneNoneNone | 1.04A | 2igtA-3aquA:undetectable | 2igtA-3aquA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2IGT_B_SAMB1002_0 (SAM DEPENDENTMETHYLTRANSFERASE) |
3aqu | AT4G19810 (Arabidopsisthaliana) | 5 / 12 | TYR A 290ALA A 238PRO A 198GLY A 188GLY A 262 | FLC A 356 (-4.6A)NoneNoneNoneNone | 1.06A | 2igtB-3aquA:undetectable | 2igtB-3aquA:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JB7_B_ACTB1169_0 (HYPOTHETICAL PROTEINPAE2307) |
4x4w | CCA TRNANUCLEOTIDYLTRANSFERASE 1, MITOCHONDRIAL (Homosapiens) | 3 / 3 | ARG A 41ARG A 177ARG A 181 | FLC A 501 (-2.5A)FLC A 501 (-2.4A)None | 0.94A | 2jb7A-4x4wA:undetectable2jb7B-4x4wA:undetectable2jb7C-4x4wA:undetectable | 2jb7A-4x4wA:18.582jb7B-4x4wA:18.582jb7C-4x4wA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JB7_B_ACTB1169_0 (HYPOTHETICAL PROTEINPAE2307) |
4x4w | CCA TRNANUCLEOTIDYLTRANSFERASE 1, MITOCHONDRIAL (Homosapiens) | 3 / 3 | ARG A 177ARG A 181ARG A 41 | FLC A 501 (-2.4A)NoneFLC A 501 (-2.5A) | 0.94A | 2jb7A-4x4wA:undetectable2jb7B-4x4wA:undetectable2jb7C-4x4wA:undetectable | 2jb7A-4x4wA:18.582jb7B-4x4wA:18.582jb7C-4x4wA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JB7_B_ACTB1169_0 (HYPOTHETICAL PROTEINPAE2307) |
4x4w | CCA TRNANUCLEOTIDYLTRANSFERASE 1, MITOCHONDRIAL (Homosapiens) | 3 / 3 | ARG A 181ARG A 41ARG A 177 | NoneFLC A 501 (-2.5A)FLC A 501 (-2.4A) | 0.85A | 2jb7A-4x4wA:undetectable2jb7B-4x4wA:undetectable2jb7C-4x4wA:undetectable | 2jb7A-4x4wA:18.582jb7B-4x4wA:18.582jb7C-4x4wA:18.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2JIH_B_097B1001_1 (ADAMTS-1) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 8 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.31A | 2jihB-4a3wA:11.6 | 2jihB-4a3wA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NMY_A_ROCA401_2 (PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 12 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 0.97A | 2nmyB-4x84A:undetectable | 2nmyB-4x84A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OW9_A_HAEA502_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 6 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.36A | 2ow9A-4a3wA:7.7 | 2ow9A-4a3wA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OW9_B_HAEB502_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.33A | 2ow9B-4a3wA:7.7 | 2ow9B-4a3wA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_C_HAEC3001_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.33A | 2ozrC-4a3wA:7.5 | 2ozrC-4a3wA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_D_HAED3002_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.39A | 2ozrD-4a3wA:7.5 | 2ozrD-4a3wA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OZR_E_HAEE3003_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.33A | 2ozrE-4a3wA:5.7 | 2ozrE-4a3wA:20.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PCP_C_1PCC212_1 (IMMUNOGLOBULIN) |
3wbd | SINGLE CHAIN FVFRAGMENT OF MAB735 (Musmusculus) | 6 / 10 | HIS A 31PHE A 94GLY A 96TYR A 101HIS A 162TYR A 160 | FLC A2001 (-3.6A)NoneNoneNoneNoneNone | 1.11A | 2pcpC-3wbdA:22.62pcpD-3wbdA:22.5 | 2pcpC-3wbdA:54.982pcpD-3wbdA:35.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PCP_C_1PCC212_1 (IMMUNOGLOBULIN) |
3wbd | SINGLE CHAIN FVFRAGMENT OF MAB735 (Musmusculus) | 7 / 10 | HIS A 31TYR A 37PHE A 94GLY A 96TYR A 101TYR A 160HIS A 162 | FLC A2001 (-3.6A)NoneNoneNoneNoneNoneNone | 0.59A | 2pcpC-3wbdA:22.62pcpD-3wbdA:22.5 | 2pcpC-3wbdA:54.982pcpD-3wbdA:35.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QD5_A_CHDA701_0 (FERROCHELATASE) |
2p4q | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING 1 (Saccharomycescerevisiae) | 4 / 8 | LEU A 372SER A 128VAL A 184GLY A 187 | NoneFLC A 502 (-2.4A)NoneNone | 1.01A | 2qd5A-2p4qA:3.0 | 2qd5A-2p4qA:21.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QHF_A_ACTA509_0 (CHORISMATE SYNTHASE) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 3 / 3 | ARG A 159GLN A 176PRO A 177 | NoneFLC A 743 (-3.8A)None | 0.98A | 2qhfA-1po0A:undetectable | 2qhfA-1po0A:20.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UY4_A_AZMA1311_1 (ENDOCHITINASE) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 6 / 9 | TYR A 88PHE A 116ASP A 194GLN A 268TYR A 270TRP A 374 | NoneFLC A 506 (-4.4A)FLC A 506 ( 3.0A)FLC A 505 ( 2.7A)FLC A 505 (-4.2A)FLC A 505 (-3.0A) | 0.43A | 2uy4A-4tx8A:23.8 | 2uy4A-4tx8A:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UY4_A_AZMA1311_1 (ENDOCHITINASE) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 6 / 9 | TYR A 88PHE A 116GLY A 158ASP A 194GLN A 268TYR A 270 | NoneFLC A 506 (-4.4A)FLC A 506 (-3.0A)FLC A 506 ( 3.0A)FLC A 505 ( 2.7A)FLC A 505 (-4.2A) | 0.93A | 2uy4A-4tx8A:23.8 | 2uy4A-4tx8A:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UY4_A_AZMA1311_1 (ENDOCHITINASE) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 5 / 9 | TYR A 88PHE A 116GLY A 159TYR A 270TRP A 374 | NoneFLC A 506 (-4.4A)FLC A 506 (-3.3A)FLC A 505 (-4.2A)FLC A 505 (-3.0A) | 0.70A | 2uy4A-4tx8A:23.8 | 2uy4A-4tx8A:23.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2W9S_C_TOPC1160_1 (DIHYDROFOLATEREDUCTASE TYPE 1FROM TN4003) |
3ikb | UNCHARACTERIZEDCONSERVED PROTEIN (Streptococcusmutans) | 5 / 10 | ILE A 83ILE A 112ILE A 11PHE A 87TYR A 54 | NoneNoneNoneNoneFLC A 196 (-4.2A) | 1.15A | 2w9sC-3ikbA:undetectable | 2w9sC-3ikbA:22.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2WGJ_A_VGHA2346_1 (HEPATOCYTE GROWTHFACTOR RECEPTOR) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 7 / 12 | GLY A 215VAL A 222ALA A 233LEU A 263TYR A 285GLY A 289ALA A 353 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 ( 4.6A)TAK A1507 (-3.5A)TAK A1507 ( 4.2A) | 0.77A | 2wgjA-4c02A:24.7 | 2wgjA-4c02A:26.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XNR_A_ACTA1001_0 (NUCLEARPOLYADENYLATEDRNA-BINDING PROTEIN3) |
4g9s | INHIBITOR OF G-TYPELYSOZYME (Escherichiacoli) | 3 / 3 | SER B 37ARG B 32GLN B 39 | FLC B 201 (-2.7A)NoneNone | 0.83A | 2xnrA-4g9sB:undetectable | 2xnrA-4g9sB:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_A_AZMA1339_1 (CLASS III CHITINASECHIA1) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 8 / 11 | TYR A 88PHE A 116ASP A 194GLN A 268TYR A 270ASN A 271ALA A 333TRP A 374 | NoneFLC A 506 (-4.4A)FLC A 506 ( 3.0A)FLC A 505 ( 2.7A)FLC A 505 (-4.2A)FLC A 504 ( 4.3A)NoneFLC A 505 (-3.0A) | 0.50A | 2xtkA-4tx8A:24.5 | 2xtkA-4tx8A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_A_AZMA1339_1 (CLASS III CHITINASECHIA1) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 6 / 11 | TYR A 88PHE A 116GLY A 158ASP A 194GLN A 268TYR A 270 | NoneFLC A 506 (-4.4A)FLC A 506 (-3.0A)FLC A 506 ( 3.0A)FLC A 505 ( 2.7A)FLC A 505 (-4.2A) | 0.96A | 2xtkA-4tx8A:24.5 | 2xtkA-4tx8A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_A_AZMA1339_1 (CLASS III CHITINASECHIA1) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 8 / 11 | TYR A 88PHE A 116GLY A 159GLN A 268TYR A 270ASN A 271ALA A 333TRP A 374 | NoneFLC A 506 (-4.4A)FLC A 506 (-3.3A)FLC A 505 ( 2.7A)FLC A 505 (-4.2A)FLC A 504 ( 4.3A)NoneFLC A 505 (-3.0A) | 0.69A | 2xtkA-4tx8A:24.5 | 2xtkA-4tx8A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_B_AZMB1339_1 (CLASS III CHITINASECHIA1) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 6 / 10 | TYR A 88PHE A 116ASP A 194GLN A 268TYR A 270TRP A 374 | NoneFLC A 506 (-4.4A)FLC A 506 ( 3.0A)FLC A 505 ( 2.7A)FLC A 505 (-4.2A)FLC A 505 (-3.0A) | 0.44A | 2xtkB-4tx8A:24.4 | 2xtkB-4tx8A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_B_AZMB1339_1 (CLASS III CHITINASECHIA1) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 5 / 10 | TYR A 88PHE A 116GLY A 158ASP A 194GLN A 268 | NoneFLC A 506 (-4.4A)FLC A 506 (-3.0A)FLC A 506 ( 3.0A)FLC A 505 ( 2.7A) | 1.05A | 2xtkB-4tx8A:24.4 | 2xtkB-4tx8A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XTK_B_AZMB1339_1 (CLASS III CHITINASECHIA1) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 5 / 10 | TYR A 88PHE A 116GLY A 159TYR A 270TRP A 374 | NoneFLC A 506 (-4.4A)FLC A 506 (-3.3A)FLC A 505 (-4.2A)FLC A 505 (-3.0A) | 0.81A | 2xtkB-4tx8A:24.4 | 2xtkB-4tx8A:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_A_CUA1338_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 3 / 3 | ASP A 257HIS A 290HIS A 231 | FLC A 501 (-3.8A)FLC A 501 (-3.8A)FLC A 501 (-3.9A) | 0.70A | 2xxgA-5jpeA:undetectable | 2xxgA-5jpeA:22.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2XXG_C_CUC1339_0 (DISSIMILATORYCOPPER-CONTAININGNITRITE REDUCTASE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 3 / 3 | ASP A 257HIS A 290HIS A 231 | FLC A 501 (-3.8A)FLC A 501 (-3.8A)FLC A 501 (-3.9A) | 0.71A | 2xxgC-5jpeA:undetectable | 2xxgC-5jpeA:22.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7H_B_SAMB530_1 (TYPE I RESTRICTIONENZYME ECOKI MPROTEIN) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 3 / 3 | TYR A 292GLU A 413THR A 378 | NoneNoneFLC A1504 ( 3.9A) | 1.04A | 2y7hB-4c02A:undetectable | 2y7hB-4c02A:21.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2Y7W_B_SALB1300_1 (LYSR-TYPE REGULATORYPROTEIN) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 5 / 10 | GLY A 346PHE A 237HIS A 159THR A 361ILE A 158 | NoneNone ZN A 508 ( 3.2A)FLC A 509 ( 4.6A)None | 1.12A | 2y7wB-5hvfA:undetectable | 2y7wB-5hvfA:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2YFB_B_ACTB501_0 (METHYL-ACCEPTINGCHEMOTAXISTRANSDUCER) |
2d4v | ISOCITRATEDEHYDROGENASE (Acidithiobacillusthiooxidans) | 4 / 6 | ASP A 324VAL A 131ARG A 129ILE A 151 | NoneNoneFLC A3001 (-3.4A)None | 1.13A | 2yfbB-2d4vA:undetectable | 2yfbB-2d4vA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZBP_A_SAMA300_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 5 / 12 | GLY A 403GLY A 189GLY A 184LEU A 216ASN A 186 | FLC A 501 ( 3.8A)NoneNoneNoneFLC A 501 (-3.7A) | 1.07A | 2zbpA-5x9rA:undetectable | 2zbpA-5x9rA:22.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZZN_B_SAMB402_0 (UNCHARACTERIZEDPROTEIN MJ0883) |
4uzy | FLAGELLAR ASSOCIATEDPROTEIN (Chlamydomonasreinhardtii) | 5 / 12 | PHE A 367LEU A 349GLY A 417ILE A 424ASP A 427 | NoneFLC A1647 (-3.9A)NoneNoneNone | 1.29A | 2zznB-4uzyA:undetectable | 2zznB-4uzyA:18.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3M_A_H4BA760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 3b3mA-4lmvA:undetectable3b3mB-4lmvA:undetectable | 3b3mA-4lmvA:21.003b3mB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3M_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 3b3mA-4lmvA:undetectable3b3mB-4lmvA:undetectable | 3b3mA-4lmvA:21.003b3mB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3B3P_B_H4BB760_1 (NITRIC-OXIDESYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 8 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 3b3pA-4lmvA:undetectable3b3pB-4lmvA:undetectable | 3b3pA-4lmvA:21.003b3pB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DD0_A_EZLA301_1 (CARBONIC ANHYDRASE 2) |
3n9t | PNPC (Pseudomonasputida) | 5 / 10 | HIS A 220HIS A 218HIS A 234VAL A 104PRO A 197 | FE A 292 ( 3.1A) FE A 292 ( 3.2A)NoneNoneFLC A 293 (-4.6A) | 1.25A | 3dd0A-3n9tA:undetectable | 3dd0A-3n9tA:23.01 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EKY_A_DR7A100_1 (PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 10 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 0.99A | 3ekyA-4x84A:undetectable | 3ekyA-4x84A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EL1_A_DR7A100_1 (PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 11 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 1.00A | 3el1A-4x84A:undetectable | 3el1A-4x84A:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FC5_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.13A | 3fc5A-4lmvA:undetectable3fc5B-4lmvA:undetectable | 3fc5A-4lmvA:20.333fc5B-4lmvA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FC5_B_H4BB761_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 3fc5A-4lmvA:undetectable3fc5B-4lmvA:undetectable | 3fc5A-4lmvA:20.333fc5B-4lmvA:20.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HCN_B_CHDB2_0 (FERROCHELATASE,MITOCHONDRIAL) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 3 / 3 | LEU B 65LEU B 39ARG B 97 | NoneNoneFLC B 292 (-2.8A) | 0.63A | 3hcnB-3d6nB:2.3 | 3hcnB-3d6nB:22.31 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HGI_A_BEZA284_0 (CATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 7 / 12 | GLY A 106PRO A 107TYR A 160TYR A 194ARG A 215HIS A 218HIS A 220 | FLC A 293 ( 4.3A)FLC A 293 (-3.5A) FE A 292 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A) | 0.34A | 3hgiA-3n9tA:27.9 | 3hgiA-3n9tA:31.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HGI_A_BEZA284_0 (CATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 6 / 12 | GLY A 106PRO A 107TYR A 194ARG A 215HIS A 218HIS A 234 | FLC A 293 ( 4.3A)FLC A 293 (-3.5A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A) FE A 292 ( 3.2A)None | 1.39A | 3hgiA-3n9tA:27.9 | 3hgiA-3n9tA:31.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3HGI_A_BEZA284_0 (CATECHOL1,2-DIOXYGENASE) |
3n9t | PNPC (Pseudomonasputida) | 6 / 12 | LEU A 77GLY A 106TYR A 194ARG A 215HIS A 218HIS A 220 | FLC A 293 (-4.4A)FLC A 293 ( 4.3A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A) FE A 292 ( 3.2A) FE A 292 ( 3.1A) | 0.89A | 3hgiA-3n9tA:27.9 | 3hgiA-3n9tA:31.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HLW_B_CE3B302_1 (CTX-M-9EXTENDED-SPECTRUMBETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 149LYS A 239THR A 240GLY A 241SER A 242GLY A 243 | FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)FLC A 301 (-2.8A)None | 0.69A | 3hlwB-5ctmA:18.9 | 3hlwB-5ctmA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSN_B_H4BB1760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 3hsnA-4lmvA:undetectable3hsnB-4lmvA:undetectable | 3hsnA-4lmvA:21.003hsnB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSO_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 3hsoA-4lmvA:undetectable3hsoB-4lmvA:undetectable | 3hsoA-4lmvA:21.003hsoB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3HSP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 3hspA-4lmvA:undetectable3hspB-4lmvA:undetectable | 3hspA-4lmvA:21.003hspB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3IJD_B_C2FB314_1 (UNCHARACTERIZEDPROTEIN) |
3b4y | PROBABLEF420-DEPENDENTGLUCOSE-6-PHOSPHATEDEHYDROGENASE FGD1 (Mycobacteriumtuberculosis) | 3 / 3 | THR A 204LYS A 259GLU A 201 | NoneFLC A 337 (-2.8A)None | 0.81A | 3ijdB-3b4yA:14.0 | 3ijdB-3b4yA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JT6_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 3jt6A-4lmvA:undetectable3jt6B-4lmvA:undetectable | 3jt6A-4lmvA:21.003jt6B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JWT_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 3jwtA-4lmvA:undetectable3jwtB-4lmvA:undetectable | 3jwtA-4lmvA:20.763jwtB-4lmvA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX0_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 3jx0A-4lmvA:undetectable3jx0B-4lmvA:undetectable | 3jx0A-4lmvA:21.003jx0B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX1_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 8 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.15A | 3jx1A-4lmvA:undetectable3jx1B-4lmvA:undetectable | 3jx1A-4lmvA:21.003jx1B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JX3_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 3jx3A-4lmvA:undetectable3jx3B-4lmvA:undetectable | 3jx3A-4lmvA:21.003jx3B-4lmvA:21.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_1 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4qsz | MALTOSE-BINDINGPERIPLASMIC PROTEIN,JMJCDOMAIN-CONTAININGPROTEIN 7 CHIMERA (Escherichiacoli;Musmusculus) | 12 / 12 | ASP A-357LYS A-356LYS A-329GLU A-327GLU A-326ALA A-308ASP A-306ARG A-305GLU A-260PRO A-217TRP A-141TYR A -30 | GLC A 901 (-2.9A)GLC A 901 (-3.0A)NoneFLC A 903 (-3.9A)FLC A 903 (-3.5A)GLC A 902 (-3.1A)GLC A 902 (-2.9A)FLC A 903 (-3.9A)GLC A 901 (-3.1A)GLC A 902 ( 3.7A)GLC A 901 (-4.0A)FLC A 903 (-3.9A) | 0.39A | 3jyrA-4qszA:60.3 | 3jyrA-4qszA:50.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4qsz | MALTOSE-BINDINGPERIPLASMIC PROTEIN,JMJCDOMAIN-CONTAININGPROTEIN 7 CHIMERA (Escherichiacoli;Musmusculus) | 6 / 7 | ASN A-359TRP A-309GLU A-218TYR A-216MET A -41TRP A -31 | GLC A 901 (-4.7A)GLC A 902 (-3.9A)FLC A 903 (-3.0A)GLC A 901 ( 3.8A)GLC A 902 ( 4.1A)GLC A 902 ( 3.6A) | 0.19A | 3jyrA-4qszA:60.3 | 3jyrA-4qszA:50.95 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3JYR_A_ACRA371_2 (MALTOSE-BINDINGPERIPLASMIC PROTEIN) |
4qsz | MALTOSE-BINDINGPERIPLASMIC PROTEIN,JMJCDOMAIN-CONTAININGPROTEIN 7 CHIMERA (Escherichiacoli;Musmusculus) | 5 / 7 | GLU A-218TYR A-216MET A -41TRP A -31ARG A -27 | FLC A 903 (-3.0A)GLC A 901 ( 3.8A)GLC A 902 ( 4.1A)GLC A 902 ( 3.6A)FLC A 903 (-2.9A) | 0.90A | 3jyrA-4qszA:60.3 | 3jyrA-4qszA:50.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3JZJ_A_ACRA405_1 (ACARBOSE/MALTOSEBINDING PROTEIN GACH) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 5 / 12 | GLU A 262GLY A 180ALA A 74ASP A 568ARG A 580 | NoneNoneFLC A 756 ( 3.8A)FLC A 756 ( 4.7A)FLC A 756 (-3.3A) | 1.28A | 3jzjA-1b0kA:0.0 | 3jzjA-1b0kA:20.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K8M_A_ACRA720_1 (ALPHA-AMYLASE, SUSG) |
4r9i | SERPIN-18 (Bombyxmori) | 4 / 7 | GLU A 287LEU A 239LYS A 272ASN A 238 | FLC A 402 (-3.8A)NoneNoneNone | 1.26A | 3k8mA-4r9iA:undetectable | 3k8mA-4r9iA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K8M_B_ACRB820_1 (ALPHA-AMYLASE, SUSG) |
4r9i | SERPIN-18 (Bombyxmori) | 4 / 7 | GLU A 287LEU A 239LYS A 272ASN A 238 | FLC A 402 (-3.8A)NoneNoneNone | 1.31A | 3k8mB-4r9iA:undetectable | 3k8mB-4r9iA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3K9F_F_LFXF0_1 (DNA TOPOISOMERASE 4SUBUNIT ADNA TOPOISOMERASE 4SUBUNIT B) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 5 | ARG A 235ARG A 302GLY A 336GLU A 338 | FLC A 509 (-2.8A)NoneNoneNone | 1.17A | 3k9fA-5hvfA:3.53k9fB-5hvfA:3.53k9fC-5hvfA:3.1 | 3k9fA-5hvfA:21.433k9fB-5hvfA:21.433k9fC-5hvfA:20.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KEC_A_HAEA272_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 5 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.29A | 3kecA-4a3wA:7.6 | 3kecA-4a3wA:21.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KP3_B_AICB2002_1 (TRANSCRIPTIONALREGULATOR TCAR) |
5ltg | AUTOPHAGY-RELATEDPROTEIN 18 (Ogataeaangusta) | 3 / 3 | ALA A 240ARG A 248LYS A 257 | NoneFLC A 602 (-3.2A)None | 1.04A | 3kp3B-5ltgA:undetectable | 3kp3B-5ltgA:17.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KVR_A_URFA2001_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | THR A 124PHE A 197ARG A 203GLU A 232MET A 233 | FLC A 301 (-3.7A)NoneNoneNoneNone | 0.38A | 3kvrA-5cyfA:41.2 | 3kvrA-5cyfA:38.71 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3KVR_B_URFB2011_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | THR A 124PHE A 197ARG A 203GLU A 232MET A 233 | FLC A 301 (-3.7A)NoneNoneNoneNone | 0.41A | 3kvrB-5cyfA:41.1 | 3kvrB-5cyfA:38.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L8L_C_DVAC6_0 (GRAMICIDIN D) |
4bj4 | AMPDH2 (Pseudomonasaeruginosa) | 3 / 3 | ALA A 87VAL A 89TRP A 97 | NoneNoneFLC A1260 (-4.9A) | 0.81A | 3l8lC-4bj4A:undetectable3l8lD-4bj4A:undetectable | 3l8lC-4bj4A:7.483l8lD-4bj4A:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LIK_A_HAEA302_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 5 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.31A | 3likA-4a3wA:8.1 | 3likA-4a3wA:26.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LIL_A_HAEA302_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.27A | 3lilA-4a3wA:8.1 | 3lilA-4a3wA:26.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LJG_A_HAEA301_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 5 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.30A | 3ljgA-4a3wA:8.2 | 3ljgA-4a3wA:26.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LKA_A_HAEA269_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 5 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.32A | 3lkaA-4a3wA:8.1 | 3lkaA-4a3wA:26.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LZS_A_017A200_2 (HIV-1 PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 12 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 0.96A | 3lzsB-4x84A:undetectable | 3lzsB-4x84A:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3LZU_A_017A200_1 (HIV-1 PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 12 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 0.95A | 3lzuA-4x84A:undetectable | 3lzuA-4x84A:19.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLP_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.15A | 3nlpA-4lmvA:undetectable3nlpB-4lmvA:undetectable | 3nlpA-4lmvA:21.003nlpB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLR_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.08A | 3nlrA-4lmvA:undetectable3nlrB-4lmvA:undetectable | 3nlrA-4lmvA:21.003nlrB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLY_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 8 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 3nlyA-4lmvA:undetectable3nlyB-4lmvA:undetectable | 3nlyA-4lmvA:21.003nlyB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NLZ_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 3nlzA-4lmvA:undetectable3nlzB-4lmvA:undetectable | 3nlzA-4lmvA:21.003nlzB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NU5_B_478B401_2 (PROTEASE) |
6eoe | 78 KDAGLUCOSE-REGULATEDPROTEIN (Cricetulusgriseus) | 5 / 12 | GLY A 397ALA A 398GLY A 403VAL A 404ILE A 199 | NoneNoneNoneFLC A 601 (-4.7A)None | 1.14A | 3nu5B-6eoeA:undetectable | 3nu5B-6eoeA:12.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NY4_A_SMXA308_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.45A | 3ny4A-5ctmA:17.9 | 3ny4A-5ctmA:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O7W_A_SAMA801_1 (LEUCINE CARBOXYLMETHYLTRANSFERASE 1) |
3wi5 | MAJOR OUTER MEMBRANEPROTEIN P.IB (Neisseriameningitidis) | 3 / 3 | LYS A 99ARG A 125ASP A 108 | FLC A 401 (-3.4A)FLC A 401 (-3.7A)None | 1.00A | 3o7wA-3wi5A:undetectable | 3o7wA-3wi5A:23.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O9M_B_BEZB999_0 (CHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 4 / 6 | GLY A 42GLY A 43SER A 111HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)FLC A 402 (-3.7A) | 0.81A | 3o9mB-5yhpA:12.8 | 3o9mB-5yhpA:21.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OG7_A_032A1_1 (AKAP9-BRAF FUSIONPROTEIN) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263GLY A 356 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)None | 0.73A | 3og7A-4c02A:25.0 | 3og7A-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OG7_A_032A1_1 (AKAP9-BRAF FUSIONPROTEIN) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.32A | 3og7A-4c02A:25.0 | 3og7A-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PHN_A_ACTA108_0 (PROTEIN P-30) |
3b4y | PROBABLEF420-DEPENDENTGLUCOSE-6-PHOSPHATEDEHYDROGENASE FGD1 (Mycobacteriumtuberculosis) | 3 / 3 | THR A 195SER A 196ARG A 283 | FLC A 337 ( 3.4A)NoneFLC A 337 (-2.8A) | 0.75A | 3phnA-3b4yA:undetectable | 3phnA-3b4yA:13.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3PNG_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 3pngA-4lmvA:undetectable3pngB-4lmvA:undetectable | 3pngA-4lmvA:21.003pngB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q07_B_WPPB400_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 5 / 12 | SER A 149LYS A 239GLY A 241SER A 242GLY A 243 | FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.2A)FLC A 301 (-2.8A)None | 0.63A | 3q07B-5ctmA:18.6 | 3q07B-5ctmA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3Q9A_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.16A | 3q9aA-4lmvA:undetectable3q9aB-4lmvA:undetectable | 3q9aA-4lmvA:21.003q9aB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S56_A_ROCA201_2 (PROTEASE) |
5wxu | 11S GLOBULIN (Wrightiatinctoria) | 5 / 9 | LEU A 162GLY A 111ILE A 112ILE A 295ILE A 160 | NoneNoneNoneFLC A 503 (-3.9A)None | 1.11A | 3s56B-5wxuA:undetectable | 3s56B-5wxuA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3T3R_A_9PLA501_1 (CYTOCHROME P450 2A6) |
2whd | THIOREDOXINREDUCTASE (Hordeumvulgare) | 5 / 11 | VAL A 216PHE A 131ILE A 253GLY A 164LEU A 249 | NoneNoneFLC A 401 (-4.2A)FLC A 401 ( 4.0A)None | 1.13A | 3t3rA-2whdA:undetectable | 3t3rA-2whdA:22.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TJ7_A_ACTA604_0 (GBAA_1210 PROTEIN) |
2bp1 | AFLATOXIN B1ALDEHYDE REDUCTASEMEMBER 2 (Homosapiens) | 4 / 6 | TYR A 226GLY A 199HIS A 142SER A 172 | NDP A1361 (-3.3A)NoneFLC A1362 ( 3.9A)NDP A1361 (-2.7A) | 1.09A | 3tj7A-2bp1A:undetectable3tj7B-2bp1A:undetectable | 3tj7A-2bp1A:18.333tj7B-2bp1A:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TJ7_A_ACTA609_0 (GBAA_1210 PROTEIN) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 3 / 3 | LYS A 108VAL A 105HIS A 104 | FLC A 203 (-2.8A)None FE A 201 ( 3.4A) | 1.14A | 3tj7A-4n6wA:undetectable | 3tj7A-4n6wA:23.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TJ7_C_ACTC606_0 (GBAA_1210 PROTEIN) |
2bp1 | AFLATOXIN B1ALDEHYDE REDUCTASEMEMBER 2 (Homosapiens) | 4 / 6 | TYR A 226GLY A 199HIS A 142SER A 172 | NDP A1361 (-3.3A)NoneFLC A1362 ( 3.9A)NDP A1361 (-2.7A) | 1.09A | 3tj7C-2bp1A:undetectable3tj7D-2bp1A:undetectable | 3tj7C-2bp1A:18.333tj7D-2bp1A:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TJ7_D_ACTD605_0 (GBAA_1210 PROTEIN) |
2bp1 | AFLATOXIN B1ALDEHYDE REDUCTASEMEMBER 2 (Homosapiens) | 4 / 6 | HIS A 142SER A 172TYR A 226GLY A 199 | FLC A1362 ( 3.9A)NDP A1361 (-2.7A)NDP A1361 (-3.3A)None | 1.12A | 3tj7C-2bp1A:undetectable3tj7D-2bp1A:undetectable | 3tj7C-2bp1A:18.333tj7D-2bp1A:18.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3TYM_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 3tymA-4lmvA:undetectable3tymB-4lmvA:undetectable | 3tymA-4lmvA:21.003tymB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UAW_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.35A | 3uawA-5cyfA:23.5 | 3uawA-5cyfA:24.92 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UAY_A_ADNA236_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121THR A 124GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)FLC A 301 (-3.7A)NoneNoneFLC A 301 (-2.8A) | 0.30A | 3uayA-5cyfA:23.9 | 3uayA-5cyfA:25.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 3ufuA-4lmvA:undetectable3ufuB-4lmvA:undetectable | 3ufuA-4lmvA:21.003ufuB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UFV_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 3ufvA-4lmvA:undetectable3ufvB-4lmvA:undetectable | 3ufvA-4lmvA:21.003ufvB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNC_A_SALA1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 5 / 9 | LEU B 39ARG B 97PHE B 41THR B 48LEU B 50 | NoneFLC B 292 (-2.8A)NoneFLC B 292 (-4.1A)None | 1.40A | 3uncA-3d6nB:undetectable | 3uncA-3d6nB:12.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UNC_B_SALB1338_1 (XANTHINEDEHYDROGENASE/OXIDASE) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 5 / 9 | LEU B 39ARG B 97PHE B 41THR B 48LEU B 50 | NoneFLC B 292 (-2.8A)NoneFLC B 292 (-4.1A)None | 1.40A | 3uncB-3d6nB:undetectable | 3uncB-3d6nB:12.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3UQ6_B_ADNB401_1 (ADENOSINE KINASE,PUTATIVE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 5 / 12 | ASP A 229LEU A 428ASN A 289THR A 430GLY A 288 | FLC A 501 (-3.1A)NoneFLC A 501 (-3.1A)NoneNone | 1.10A | 3uq6B-5jpeA:undetectable | 3uq6B-5jpeA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V4T_D_ACTD502_0 (UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE) |
2p4q | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING 1 (Saccharomycescerevisiae) | 3 / 3 | GLY A 262THR A 265ASN A 186 | NoneNoneFLC A 502 (-2.6A) | 0.68A | 3v4tD-2p4qA:1.3 | 3v4tD-2p4qA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VAQ_B_ADNB401_1 (PUTATIVE ADENOSINEKINASE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 5 / 12 | ASP A 229LEU A 428ASN A 289THR A 430GLY A 288 | FLC A 501 (-3.1A)NoneFLC A 501 (-3.1A)NoneNone | 1.12A | 3vaqB-5jpeA:undetectable | 3vaqB-5jpeA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VYW_C_SAMC401_1 (MNMC2) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 6 | GLY A 641GLU A 640ASP A 568ASN A 448 | NoneNoneFLC A 756 ( 4.7A)None | 0.91A | 3vywC-1b0kA:undetectable | 3vywC-1b0kA:18.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ZS3_A_ACTA1224_0 (THAUMATIN-LIKEPROTEIN) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 4 / 5 | SER A 57GLU A 107THR A 60ASP A 85 | NoneFLC A 300 ( 4.1A)NoneNone | 1.17A | 3zs3A-4x84A:undetectable | 3zs3A-4x84A:22.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A3U_A_ACTA1358_0 (NADH:FLAVINOXIDOREDUCTASE/NADHOXIDASE) |
4iis | BETA-1,3-GLUCANASEFORM 'RRII GLN 2' (Heveabrasiliensis) | 5 / 9 | ALA A 134ARG A 32GLY A 54VAL A 55ASN A 93 | NoneNoneNoneNoneFLC A 402 (-4.5A) | 0.99A | 4a3uA-4iisA:5.7 | 4a3uA-4iisA:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4A7B_A_HAEA1273_1 (COLLAGENASE 3) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 6 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.40A | 4a7bA-4a3wA:7.4 | 4a7bA-4a3wA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AN2_A_EUIA1382_1 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | LEU A 281ASP A 336LYS A 338ASN A 341ASP A 354GLY A 356 | NoneNoneFLC A1504 (-2.8A)NoneTAK A1507 (-3.5A)None | 1.33A | 4an2A-4c02A:22.5 | 4an2A-4c02A:26.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4AN2_A_EUIA1382_1 (DUAL SPECIFICITYMITOGEN-ACTIVATEDPROTEIN KINASEKINASE 1) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | LYS A 235ASP A 336LYS A 338ASN A 341ASP A 354 | TAK A1507 ( 4.5A)NoneFLC A1504 (-2.8A)NoneTAK A1507 (-3.5A) | 0.65A | 4an2A-4c02A:22.5 | 4an2A-4c02A:26.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BZ6_C_SHHC700_1 (HISTONE DEACETYLASE8) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 12 | HIS A 260GLY A 323HIS A 232PRO A 156HIS A 180 | NoneFLC A 424 (-3.2A)FLC A 424 (-4.8A)NoneFLC A 424 (-4.0A) | 1.21A | 4bz6C-3d6nA:undetectable | 4bz6C-3d6nA:22.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C1F_A_X8ZA300_1 (BETA-LACTAMASE IMP-1) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 11 | HIS A 180ASP A 153HIS A 232ASN A 278HIS A 63 | FLC A 424 (-4.0A) ZN A 423 ( 2.4A)FLC A 424 (-4.8A)FLC A 424 (-4.8A) ZN A 423 ( 3.4A) | 1.27A | 4c1fA-3d6nA:undetectable4c1fB-3d6nA:undetectable | 4c1fA-3d6nA:21.844c1fB-3d6nA:21.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_A_0LIA1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 7 / 12 | ALA A 233LYS A 235LEU A 263THR A 283HIS A 334LEU A 343ALA A 353 | TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneTAK A1507 (-4.7A)TAK A1507 ( 4.2A) | 0.52A | 4c8bA-4c02A:24.2 | 4c8bA-4c02A:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C8B_B_0LIB1000_1 (RECEPTOR-INTERACTINGSERINE/THREONINE-PROTEIN KINASE 2) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 8 / 12 | ALA A 233LYS A 235ILE A 262LEU A 263THR A 283HIS A 334LEU A 343ALA A 353 | TAK A1507 (-3.3A)TAK A1507 ( 4.5A)NoneFLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneTAK A1507 (-4.7A)TAK A1507 ( 4.2A) | 0.69A | 4c8bB-4c02A:24.2 | 4c8bB-4c02A:27.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAN_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.08A | 4canA-4lmvA:undetectable4canB-4lmvA:undetectable | 4canA-4lmvA:21.004canB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CAP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 4capA-4lmvA:undetectable4capB-4lmvA:undetectable | 4capA-4lmvA:21.004capB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTR_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.06A | 4ctrA-4lmvA:undetectable4ctrB-4lmvA:undetectable | 4ctrA-4lmvA:21.004ctrB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTU_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 4ctuA-4lmvA:undetectable4ctuB-4lmvA:undetectable | 4ctuA-4lmvA:21.004ctuB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4CTW_A_H4BA1718_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 4ctwA-4lmvA:undetectable4ctwB-4lmvA:undetectable | 4ctwA-4lmvA:21.004ctwB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D1N_C_H4BC760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.15A | 4d1nC-4lmvA:undetectable4d1nD-4lmvA:undetectable | 4d1nC-4lmvA:21.094d1nD-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D2Y_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 4d2yA-4lmvA:undetectable4d2yB-4lmvA:undetectable | 4d2yA-4lmvA:21.004d2yB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D2Y_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 4d2yA-4lmvA:undetectable4d2yB-4lmvA:undetectable | 4d2yA-4lmvA:21.004d2yB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D30_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 4d30A-4lmvA:undetectable4d30B-4lmvA:undetectable | 4d30A-4lmvA:21.004d30B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D3B_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 4d3bA-4lmvA:undetectable4d3bB-4lmvA:undetectable | 4d3bA-4lmvA:21.004d3bB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D9H_A_ADNA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121GLU A 232MET A 233GLU A 234VAL A 257 | FLC A 301 (-3.0A)NoneNoneFLC A 301 (-2.8A)None | 0.90A | 4d9hA-5cyfA:24.4 | 4d9hA-5cyfA:26.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DA7_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 10 | ARG A 121ALA A 194GLU A 232MET A 233GLU A 234 | FLC A 301 (-3.0A)NoneNoneNoneFLC A 301 (-2.8A) | 0.36A | 4da7A-5cyfA:24.3 | 4da7A-5cyfA:26.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DAN_A_2FAA301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 11 | ARG A 121GLU A 232MET A 233GLU A 234VAL A 257 | FLC A 301 (-3.0A)NoneNoneFLC A 301 (-2.8A)None | 0.95A | 4danA-5cyfA:23.9 | 4danA-5cyfA:26.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DAN_B_2FAB301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 5 / 12 | ARG A 121GLU A 232MET A 233GLU A 234VAL A 257 | FLC A 301 (-3.0A)NoneNoneFLC A 301 (-2.8A)None | 0.95A | 4danA-5cyfA:23.94danB-5cyfA:23.8 | 4danA-5cyfA:26.324danB-5cyfA:26.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1G_B_LNLB701_1 (PROSTAGLANDIN G/HSYNTHASE 2) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 5 / 12 | ARG A 644GLY A 641ALA A 642SER A 166GLY A 180 | FLC A 756 (-4.3A)NoneFLC A 756 (-3.0A)FLC A 756 (-2.6A)None | 0.91A | 4e1gB-1b0kA:0.0 | 4e1gB-1b0kA:21.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_A_URFA1301_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.43A | 4e1vA-5cyfA:25.1 | 4e1vA-5cyfA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_C_URFC1301_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.46A | 4e1vC-5cyfA:24.7 | 4e1vC-5cyfA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_D_URFD1301_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.50A | 4e1vD-5cyfA:24.8 | 4e1vD-5cyfA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_E_URFE1301_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.46A | 4e1vE-5cyfA:25.3 | 4e1vE-5cyfA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_G_URFG1301_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.56A | 4e1vG-5cyfA:24.1 | 4e1vG-5cyfA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E1V_H_URFH1301_1 (URIDINEPHOSPHORYLASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 8 | THR A 124ARG A 203MET A 233VAL A 257 | FLC A 301 (-3.7A)NoneNoneNone | 0.52A | 4e1vH-5cyfA:24.8 | 4e1vH-5cyfA:26.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EOH_A_TEPA402_1 (PYRIDOXAL KINASE) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 4 / 5 | SER A 123THR A 129VAL A 105ASP A 161 | FLC A 203 ( 4.5A)FLC A 203 (-3.2A)None FE A 202 ( 2.5A) | 0.96A | 4eohA-4n6wA:undetectable | 4eohA-4n6wA:21.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_A_GNTA604_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 12 | GLY A 42GLY A 43SER A 111PHE A 236HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)NoneFLC A 402 (-3.7A) | 0.86A | 4ey6A-5yhpA:13.0 | 4ey6A-5yhpA:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4EY6_B_GNTB605_1 (ACETYLCHOLINESTERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 12 | GLY A 42GLY A 43SER A 111PHE A 236HIS A 297 | FLC A 402 ( 3.8A)FLC A 402 (-3.4A)FLC A 402 (-2.5A)NoneFLC A 402 (-3.7A) | 0.86A | 4ey6B-5yhpA:11.3 | 4ey6B-5yhpA:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FVZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.15A | 4fvzA-4lmvA:undetectable4fvzB-4lmvA:undetectable | 4fvzA-4lmvA:21.004fvzB-4lmvA:21.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4G19_B_ACTB301_0 (GLUTATHIONETRANSFERASE GTE1) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 5 | ASN A 24TYR A 46TRP A 122ARG A 154 | NoneFLC A 300 (-3.7A)NoneFLC A 300 (-3.1A) | 0.88A | 4g19B-4lmvA:40.7 | 4g19B-4lmvA:73.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4H9M_A_HAEA929_1 (UREASE) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 4 / 5 | HIS A 61HIS A 180HIS A 232ASP A 305 | ZN A 423 (-3.5A)FLC A 424 (-4.0A)FLC A 424 (-4.8A)FLC A 424 ( 2.7A) | 0.45A | 4h9mA-3d6nA:24.3 | 4h9mA-3d6nA:20.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4H9M_A_HAEA929_1 (UREASE) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 5 / 5 | HIS A 58HIS A 62HIS A 80HIS A 104ASP A 161 | FE A 202 (-3.3A)FLC A 203 (-4.0A) FE A 201 ( 3.4A) FE A 201 ( 3.4A) FE A 202 ( 2.5A) | 0.93A | 4h9mA-4n6wA:undetectable | 4h9mA-4n6wA:14.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4HDL_A_DXCA75_0 (PPCA) |
4a1f | REPLICATIVE DNAHELICASE (Helicobacterpylori) | 4 / 8 | ILE A 384LYS A 209ILE A 440PHE A 387 | NoneFLC A1474 (-3.2A)NoneNone | 0.91A | 4hdlA-4a1fA:undetectable | 4hdlA-4a1fA:11.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4I13_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
3zh4 | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Streptococcuspneumoniae) | 3 / 3 | ASP A 326ARG A 92THR A 297 | NoneFLC A1419 ( 4.0A)None | 0.74A | 4i13A-3zh4A:undetectable | 4i13A-3zh4A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IB4_A_ERMA2001_1 (CHIMERA PROTEIN OFHUMAN5-HYDROXYTRYPTAMINERECEPTOR 2B AND E.COLI SOLUBLECYTOCHROME B562) |
4blp | PACKAGING ENZYME P4 (Pseudomonasphagephi13) | 5 / 12 | VAL A 282VAL A 277ALA A 157LEU A 218VAL A 219 | NoneNoneFLC A1304 ( 4.0A)NoneNone | 1.25A | 4ib4A-4blpA:undetectable | 4ib4A-4blpA:22.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4J4V_C_SVRC301_1 (NUCLEOCAPSID PROTEIN) |
3b4y | PROBABLEF420-DEPENDENTGLUCOSE-6-PHOSPHATEDEHYDROGENASE FGD1 (Mycobacteriumtuberculosis) | 4 / 8 | GLY A 177ARG A 283MET A 208PHE A 192 | F42 A 338 (-3.4A)FLC A 337 (-2.8A)NoneNone | 0.99A | 4j4vC-3b4yA:undetectable | 4j4vC-3b4yA:24.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JSF_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 4jsfA-4lmvA:undetectable4jsfB-4lmvA:undetectable | 4jsfA-4lmvA:21.004jsfB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4KCM_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 4kcmA-4lmvA:undetectable4kcmB-4lmvA:undetectable | 4kcmA-4lmvA:21.004kcmB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4LG1_C_SAMC301_0 (PROTEIN-LYSINEMETHYLTRANSFERASEMETTL21D) |
4jxr | ACETYLTRANSFERASE (Sinorhizobiummeliloti) | 5 / 12 | ALA A 58GLY A 98GLY A 100LEU A 133ALA A 3 | NoneFLC A 201 ( 4.4A)FLC A 201 (-3.5A)FLC A 201 (-4.3A)None | 1.16A | 4lg1C-4jxrA:undetectable | 4lg1C-4jxrA:23.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4MBS_B_MRVB1101_2 (CHIMERA PROTEIN OFC-C CHEMOKINERECEPTOR TYPE 5 ANDRUBREDOXIN) |
3blw | ISOCITRATEDEHYDROGENASE [NAD]SUBUNIT 1 (Saccharomycescerevisiae) | 4 / 5 | THR A 179LEU A 233THR A 241MET A 238 | NoneNoneFLC A1001 (-2.6A)None | 1.49A | 4mbsB-3blwA:undetectable | 4mbsB-3blwA:21.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N49_A_SAMA601_0 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
2p4q | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING 1 (Saccharomycescerevisiae) | 5 / 12 | GLY A 187GLY A 191THR A 265ASN A 186ILE A 267 | NoneNoneNoneFLC A 502 (-2.6A)None | 0.97A | 4n49A-2p4qA:3.1 | 4n49A-2p4qA:22.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJH_A_SAMA302_0 (7-CARBOXY-7-DEAZAGUANINE SYNTHASE) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 5 / 12 | THR A 234GLU A 235ASN A 231LYS A 275ASP A 218 | FLC A 302 (-4.0A)NoneNoneNoneNone | 1.49A | 4njhA-4to8A:4.7 | 4njhA-4to8A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJH_B_SAMB302_0 (7-CARBOXY-7-DEAZAGUANINE SYNTHASE) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 5 / 12 | THR A 234GLU A 235ASN A 231LYS A 275ASP A 218 | FLC A 302 (-4.0A)NoneNoneNoneNone | 1.49A | 4njhB-4to8A:3.2 | 4njhB-4to8A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJI_A_SAMA302_0 (7-CARBOXY-7-DEAZAGUANINE SYNTHASE) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 5 / 12 | THR A 234GLU A 235ASN A 231LYS A 275ASP A 218 | FLC A 302 (-4.0A)NoneNoneNoneNone | 1.50A | 4njiA-4to8A:4.7 | 4njiA-4to8A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJI_B_SAMB302_0 (7-CARBOXY-7-DEAZAGUANINE SYNTHASE) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 5 / 12 | THR A 234GLU A 235ASN A 231LYS A 275ASP A 218 | FLC A 302 (-4.0A)NoneNoneNoneNone | 1.49A | 4njiB-4to8A:2.3 | 4njiB-4to8A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJJ_A_SAMA302_0 (7-CARBOXY-7-DEAZAGUANINE SYNTHASE) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 5 / 12 | THR A 234GLU A 235ASN A 231LYS A 275ASP A 218 | FLC A 302 (-4.0A)NoneNoneNoneNone | 1.50A | 4njjA-4to8A:4.8 | 4njjA-4to8A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJJ_B_SAMB302_0 (7-CARBOXY-7-DEAZAGUANINE SYNTHASE) |
4to8 | FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE,CLASS II (Staphylococcusaureus) | 5 / 12 | THR A 234GLU A 235ASN A 231LYS A 275ASP A 218 | FLC A 302 (-4.0A)NoneNoneNoneNone | 1.48A | 4njjB-4to8A:3.4 | 4njjB-4to8A:21.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJV_A_RITA500_1 (PROTEASE) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 12 | GLY A 101ALA A 102GLY A 200ILE A 97ILE A 172 | FLC A 300 (-3.3A)NoneNoneNoneNone | 1.05A | 4njvA-4x84A:undetectable | 4njvA-4x84A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NKV_B_AERB601_2 (STEROID17-ALPHA-HYDROXYLASE/17,20 LYASE) |
3zh4 | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Streptococcuspneumoniae) | 4 / 5 | ARG A 234ASP A 306GLU A 236VAL A 378 | NoneFLC A1419 (-3.0A)NoneNone | 1.37A | 4nkvB-3zh4A:undetectable | 4nkvB-3zh4A:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0S_A_ADNA500_1 (AURORA KINASE A) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 8 / 11 | GLY A 215VAL A 222ALA A 233LYS A 235LEU A 263ASN A 341LEU A 343ASP A 354 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)NoneTAK A1507 (-4.7A)TAK A1507 (-3.5A) | 0.67A | 4o0sA-4c02A:24.9 | 4o0sA-4c02A:25.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0U_A_ADNA501_1 (AURORA KINASE A) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 4 / 6 | ALA A 233LYS A 235LEU A 263LEU A 343 | TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-4.7A) | 0.79A | 4o0uA-4c02A:8.0 | 4o0uA-4c02A:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4O0U_A_ADNA501_1 (AURORA KINASE A) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 4 / 6 | VAL A 222ALA A 233LEU A 263LEU A 343 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-4.7A) | 0.42A | 4o0uA-4c02A:8.0 | 4o0uA-4c02A:25.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P3Q_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
3zh4 | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Streptococcuspneumoniae) | 4 / 5 | ASP A 326ARG A 398ARG A 92THR A 297 | NoneFLC A1419 (-2.9A)FLC A1419 ( 4.0A)None | 1.27A | 4p3qA-3zh4A:undetectable | 4p3qA-3zh4A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4P3R_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
3zh4 | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Streptococcuspneumoniae) | 3 / 3 | ASP A 326ARG A 92THR A 297 | NoneFLC A1419 ( 4.0A)None | 0.74A | 4p3rA-3zh4A:undetectable | 4p3rA-3zh4A:15.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PFJ_A_ADNA502_2 (ADENOSYLHOMOCYSTEINASE) |
3uto | TWITCHIN (Caenorhabditiselegans) | 4 / 7 | GLU A 477THR A 301HIS A 275LEU A 265 | FLC A 573 ( 4.7A)NoneNoneNone | 1.02A | 4pfjA-3utoA:undetectable | 4pfjA-3utoA:18.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PM5_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 149LYS A 239THR A 240GLY A 241SER A 242GLY A 243 | FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)FLC A 301 (-2.8A)None | 0.59A | 4pm5A-5ctmA:18.7 | 4pm5A-5ctmA:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PM9_A_CE3A301_1 (BETA-LACTAMASECTX-M-14) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 5 / 12 | SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.37A | 4pm9A-5ctmA:18.9 | 4pm9A-5ctmA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4PQA_A_X8ZA401_1 (SUCCINYL-DIAMINOPIMELATE DESUCCINYLASE) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 6 / 11 | GLU A 268GLU A 267GLY A 274GLY A 273ILE A 233HIS A 230 | FLC A 501 ( 3.0A)NoneNoneNoneNone ZN A 500 ( 3.3A) | 1.38A | 4pqaA-1zb7A:undetectable | 4pqaA-1zb7A:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QB9_D_PARD500_1 (ENHANCEDINTRACELLULARSURVIVAL PROTEIN) |
2q7b | ACETYLTRANSFERASE,GNAT FAMILY (Streptococcusagalactiae) | 4 / 8 | SER A 110ASP A 74ASP A 73TYR A 147 | NoneNoneNoneFLC A 164 (-4.7A) | 1.26A | 4qb9D-2q7bA:10.6 | 4qb9D-2q7bA:18.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4QI9_C_MTXC201_1 (DIHYDROFOLATEREDUCTASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 11 | ALA A 87ASP A 82SER A 71ILE A 231ARG A 230 | NoneNoneNoneNoneFLC A 401 (-3.6A) | 1.16A | 4qi9C-5yhpA:undetectable | 4qi9C-5yhpA:17.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4R21_B_STRB601_1 (CYTOCHROME P450FAMILY 17POLYPEPTIDE 2) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 5 / 9 | VAL B 160GLY B 120ALA B 119THR B 48ILE B 285 | NoneNoneNoneFLC B 292 (-4.1A)None | 0.97A | 4r21B-3d6nB:undetectable | 4r21B-3d6nB:20.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RP8_C_ASCC501_1 (ASCORBATE-SPECIFICPERMEASE IICCOMPONENT ULAA) |
1p0z | SENSOR KINASE CITA (Klebsiellapneumoniae) | 3 / 3 | SER A 105TYR A 56ASP A 83 | NoneFLC A1632 (-3.8A)OMO A1631 (-3.9A) | 0.83A | 4rp8C-1p0zA:0.0 | 4rp8C-1p0zA:12.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_A_RPBA1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 5 / 11 | GLN A 176GLY A 204TYR A 520SER A 207GLU A 535 | FLC A 743 (-3.8A)NoneNoneNoneNone | 1.38A | 4rv6A-1po0A:undetectable | 4rv6A-1po0A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RV6_B_RPBB1103_1 (POLY [ADP-RIBOSE]POLYMERASE 1) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 5 / 11 | GLN A 176GLY A 204TYR A 520SER A 207GLU A 535 | FLC A 743 (-3.8A)NoneNoneNoneNone | 1.38A | 4rv6B-1po0A:undetectable | 4rv6B-1po0A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_A_032A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | ALA A 233LYS A 235LEU A 263THR A 283SER A 290 | TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)None | 0.74A | 4rzvA-4c02A:7.3 | 4rzvA-4c02A:29.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4RZV_B_032B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283SER A 290 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)None | 0.70A | 4rzvB-4c02A:24.6 | 4rzvB-4c02A:29.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UBP_C_HAEC800_1 (PROTEIN (UREASE(CHAIN C))) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 6 | HIS A 61HIS A 63HIS A 180HIS A 232ASP A 305 | ZN A 423 (-3.5A) ZN A 423 ( 3.4A)FLC A 424 (-4.0A)FLC A 424 (-4.8A)FLC A 424 ( 2.7A) | 0.43A | 4ubpC-3d6nA:23.3 | 4ubpC-3d6nA:24.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UBP_C_HAEC800_1 (PROTEIN (UREASE(CHAIN C))) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 5 / 6 | HIS A 58HIS A 62HIS A 80HIS A 104ASP A 161 | FE A 202 (-3.3A)FLC A 203 (-4.0A) FE A 201 ( 3.4A) FE A 201 ( 3.4A) FE A 202 ( 2.5A) | 0.90A | 4ubpC-4n6wA:undetectable | 4ubpC-4n6wA:16.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCH_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.14A | 4uchA-4lmvA:undetectable4uchB-4lmvA:undetectable | 4uchA-4lmvA:21.094uchB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCK_A_SAMA2409_1 (RNA-DIRECTED RNAPOLYMERASE L) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 3 / 3 | SER A 643ASP A 67ASP A 185 | FLC A 756 (-2.8A)NoneNone | 0.74A | 4uckA-1b0kA:undetectable | 4uckA-1b0kA:20.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH3_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 4uh3A-4lmvA:undetectable4uh3B-4lmvA:undetectable | 4uh3A-4lmvA:21.004uh3B-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH5_A_H4BA760_1 (NEURONAL NITRICOXIDE SYNTHASE) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.14A | 4uh5A-4lmvA:undetectable4uh5B-4lmvA:undetectable | 4uh5A-4lmvA:21.094uh5B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UH6_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 4uh6A-4lmvA:undetectable4uh6B-4lmvA:undetectable | 4uh6A-4lmvA:21.094uh6B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UPP_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 4uppA-4lmvA:undetectable4uppB-4lmvA:undetectable | 4uppA-4lmvA:21.004uppB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 4v3uA-4lmvA:undetectable4v3uB-4lmvA:undetectable | 4v3uA-4lmvA:21.094v3uB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 4v3uA-4lmvA:undetectable4v3uB-4lmvA:undetectable | 4v3uA-4lmvA:21.094v3uB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_C_H4BC760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.15A | 4v3uC-4lmvA:undetectable4v3uD-4lmvA:undetectable | 4v3uC-4lmvA:21.094v3uD-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3U_D_H4BD760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 4v3uC-4lmvA:undetectable4v3uD-4lmvA:undetectable | 4v3uC-4lmvA:21.094v3uD-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3W_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 4v3wA-4lmvA:undetectable4v3wB-4lmvA:undetectable | 4v3wA-4lmvA:21.004v3wB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3X_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 4v3xA-4lmvA:undetectable4v3xB-4lmvA:undetectable | 4v3xA-4lmvA:21.004v3xB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3Z_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.14A | 4v3zA-4lmvA:undetectable4v3zB-4lmvA:undetectable | 4v3zA-4lmvA:21.004v3zB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V3Z_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 4v3zA-4lmvA:undetectable4v3zB-4lmvA:undetectable | 4v3zA-4lmvA:21.004v3zB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XQE_A_AG2A506_1 (HOMOSPERMIDINESYNTHASE) |
5h5b | THYMIDYLATE KINASE (Aquifexaeolicus) | 4 / 6 | ARG B 145ARG B 47ARG B 90ASP B 9 | FLC B 201 (-3.0A)NoneNoneFLC B 201 (-4.6A) | 1.12A | 4xqeA-5h5bB:2.2 | 4xqeA-5h5bB:17.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XQG_A_AG2A505_1 (HOMOSPERMIDINESYNTHASE) |
5h5b | THYMIDYLATE KINASE (Aquifexaeolicus) | 4 / 8 | ARG B 145ARG B 47ARG B 90ASP B 9 | FLC B 201 (-3.0A)NoneNoneFLC B 201 (-4.6A) | 1.09A | 4xqgA-5h5bB:undetectable | 4xqgA-5h5bB:16.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XQG_B_AG2B505_1 (HOMOSPERMIDINESYNTHASE) |
5h5b | THYMIDYLATE KINASE (Aquifexaeolicus) | 4 / 8 | ARG B 145ARG B 47ARG B 90ASP B 9 | FLC B 201 (-3.0A)NoneNoneFLC B 201 (-4.6A) | 1.09A | 4xqgB-5h5bB:undetectable | 4xqgB-5h5bB:16.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XUD_A_SAMA303_0 (CATECHOLO-METHYLTRANSFERASE) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 5 / 12 | VAL A 271GLU A 232GLY A 43ILE A 231SER A 71 | NoneNoneFLC A 402 (-3.4A)NoneNone | 1.43A | 4xudA-5yhpA:2.7 | 4xudA-5yhpA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XV2_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.41A | 4xv2A-4c02A:24.3 | 4xv2A-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YDQ_A_HFGA802_1 (PROLINE--TRNA LIGASE) |
5cyf | PUTATIVE URIDINEPHOSPHORYLASE (Schistosomamansoni) | 4 / 4 | THR A 193GLU A 232THR A 98HIS A 91 | NoneNoneNoneFLC A 301 (-4.3A) | 1.35A | 4ydqA-5cyfA:2.6 | 4ydqA-5cyfA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YMG_B_SAMB1001_1 (PUTATIVESAM-DEPENDENTO-METHYLTRANFERASE) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 3 / 3 | SER A 174GLU A 268GLU A 357 | NoneFLC A 501 ( 3.0A)None | 0.75A | 4ymgB-1zb7A:undetectable | 4ymgB-1zb7A:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4Z3O_F_MFXF101_1 (DNA TOPOISOMERASE 4SUBUNITB,PARE30-PARC55FUSED TOPO IV FROMS. PNEUMONIAEE-SITE DNA) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 5 | ARG A 235ARG A 302GLY A 336GLU A 338 | FLC A 509 (-2.8A)NoneNoneNone | 1.16A | 4z3oA-5hvfA:3.84z3oB-5hvfA:4.3 | 4z3oA-5hvfA:20.114z3oB-5hvfA:20.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ZE1_A_X2NA602_1 (LANOSTEROL 14-ALPHADEMETHYLASE) |
3n9t | PNPC (Pseudomonasputida) | 5 / 12 | GLY A 106PHE A 285LEU A 219HIS A 220PHE A 236 | FLC A 293 ( 4.3A)NoneNone FE A 292 ( 3.1A)None | 1.28A | 4ze1A-3n9tA:undetectable | 4ze1A-3n9tA:21.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5A06_B_SORB1341_0 (ALDOSE-ALDOSEOXIDOREDUCTASE) |
5htk | 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2 (Homosapiens) | 4 / 7 | ARG A 136PHE A 90ARG A 78ILE A 101 | NoneNoneFLC A 601 (-3.9A)None | 1.40A | 5a06B-5htkA:undetectable | 5a06B-5htkA:20.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADB_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 5adbA-4lmvA:undetectable5adbB-4lmvA:undetectable | 5adbA-4lmvA:21.005adbB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADC_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.11A | 5adcA-4lmvA:undetectable5adcB-4lmvA:undetectable | 5adcA-4lmvA:21.005adcB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ADD_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 5addA-4lmvA:undetectable5addB-4lmvA:undetectable | 5addA-4lmvA:21.005addB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AGN_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.14A | 5agnA-4lmvA:undetectable5agnB-4lmvA:undetectable | 5agnA-4lmvA:21.005agnB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AMK_A_EF2A151_1 (CEREBLON ISOFORM 4) |
3som | METHYLMALONICACIDURIA ANDHOMOCYSTINURIA TYPEC PROTEIN (Homosapiens) | 4 / 8 | PRO A 56PHE A 223PHE A 154TYR A 205 | NoneFLC A 501 (-3.9A)NoneNone | 1.17A | 5amkA-3somA:undetectable | 5amkA-3somA:19.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AMK_A_EF2A151_1 (CEREBLON ISOFORM 4) |
4tx8 | PROBABLE CHITINASE A (Chromobacteriumviolaceum) | 4 / 8 | ASN A 94PRO A 95PHE A 92TRP A 374 | NoneNoneNoneFLC A 505 (-3.0A) | 1.44A | 5amkA-4tx8A:undetectable | 5amkA-4tx8A:15.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BTA_G_MFXG101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BDNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 7 | ARG A 235ARG A 302GLY A 336GLU A 338 | FLC A 509 (-2.8A)NoneNoneNone | 0.93A | 5btaA-5hvfA:3.45btaC-5hvfA:2.95btaD-5hvfA:2.9 | 5btaA-5hvfA:20.355btaC-5hvfA:20.355btaD-5hvfA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BTA_H_MFXH101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BDNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 6 | ARG A 302GLY A 336GLU A 338ARG A 235 | NoneNoneNoneFLC A 509 (-2.8A) | 0.91A | 5btaA-5hvfA:3.45btaB-5hvfA:3.15btaC-5hvfA:undetectable | 5btaA-5hvfA:20.355btaB-5hvfA:19.555btaC-5hvfA:20.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BTC_G_CPFG101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BDNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 6 | ARG A 235ARG A 302GLY A 336GLU A 338 | FLC A 509 (-2.8A)NoneNoneNone | 0.94A | 5btcA-5hvfA:3.15btcC-5hvfA:3.45btcD-5hvfA:2.8 | 5btcA-5hvfA:20.355btcC-5hvfA:20.355btcD-5hvfA:19.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BTC_G_CPFG102_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BDNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 6 | ARG A 302GLY A 336GLU A 338ARG A 235 | NoneNoneNoneFLC A 509 (-2.8A) | 0.91A | 5btcA-5hvfA:3.15btcB-5hvfA:2.05btcC-5hvfA:3.4 | 5btcA-5hvfA:20.355btcB-5hvfA:19.555btcC-5hvfA:20.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BTF_F_GFNF101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BDNA SUBSTRATE 24-MERTTACGTGCATAGTCATTCATGACC) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 7 | ARG A 302GLY A 336GLU A 338ARG A 235 | NoneNoneNoneFLC A 509 (-2.8A) | 0.92A | 5btfA-5hvfA:3.45btfB-5hvfA:3.95btfC-5hvfA:3.3 | 5btfA-5hvfA:20.355btfB-5hvfA:19.555btfC-5hvfA:20.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BTG_E_LFXE101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNIT BDNA SUBSTRATE 24-MERGGTCATGAATGACTATGCACGTAA) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 6 | ARG A 302GLY A 336GLU A 338ARG A 235 | NoneNoneNoneFLC A 509 (-2.8A) | 0.85A | 5btgA-5hvfA:3.55btgB-5hvfA:2.85btgC-5hvfA:3.4 | 5btgA-5hvfA:19.775btgB-5hvfA:19.555btgC-5hvfA:19.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5C0O_F_SAMF301_0 (TRNA(ADENINE(58)-N(1))-METHYLTRANSFERASETRMI) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 5 / 12 | GLY A 200GLY A 99GLY A 100ALA A 203LEU A 130 | NoneFLC A 300 (-3.8A)FLC A 300 (-3.5A)NoneNone | 0.77A | 5c0oF-4x84A:3.1 | 5c0oF-4x84A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CDQ_E_MFXE2101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB) |
3mcf | DIPHOSPHOINOSITOLPOLYPHOSPHATEPHOSPHOHYDROLASE3-ALPHA (Homosapiens) | 4 / 5 | SER A 39GLY A 51GLU A 53ARG A 115 | FLC A 0 (-3.0A)NoneNoneFLC A 0 (-3.1A) | 1.04A | 5cdqA-3mcfA:undetectable5cdqB-3mcfA:undetectable5cdqC-3mcfA:undetectable | 5cdqA-3mcfA:14.145cdqB-3mcfA:22.805cdqC-3mcfA:14.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CDQ_E_MFXE2101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 5 | ARG A 302GLY A 336GLU A 338ARG A 235 | NoneNoneNoneFLC A 509 (-2.8A) | 1.12A | 5cdqA-5hvfA:undetectable5cdqB-5hvfA:3.75cdqC-5hvfA:undetectable | 5cdqA-5hvfA:22.505cdqB-5hvfA:18.505cdqC-5hvfA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CDQ_V_MFXV2101_1 (DNA GYRASE SUBUNIT ADNA GYRASE SUBUNITB,DNA GYRASE SUBUNITB) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 4 / 5 | ARG A 302GLY A 336GLU A 338ARG A 235 | NoneNoneNoneFLC A 509 (-2.8A) | 1.16A | 5cdqR-5hvfA:undetectable5cdqS-5hvfA:undetectable5cdqT-5hvfA:undetectable | 5cdqR-5hvfA:22.505cdqS-5hvfA:18.505cdqT-5hvfA:22.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | PHE A 237VAL A 222ALA A 233LEU A 263THR A 283 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.85A | 5cswA-4c02A:24.3 | 5cswA-4c02A:29.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.41A | 5cswA-4c02A:24.3 | 5cswA-4c02A:29.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | PHE A 237VAL A 222ALA A 233LEU A 263THR A 283 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.84A | 5cswB-4c02A:24.3 | 5cswB-4c02A:29.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CSW_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.51A | 5cswB-4c02A:24.3 | 5cswB-4c02A:29.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DB5_A_CYSA503_0 (CYSTEINE DESULFURASE) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | ALA A 573HIS A 101ARG A 644ARG A 580 | NoneFLC A 756 ( 3.8A)FLC A 756 (-4.3A)FLC A 756 (-3.3A) | 1.20A | 5db5A-1b0kA:undetectable5db5B-1b0kA:undetectable | 5db5A-1b0kA:20.085db5B-1b0kA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DB5_A_CYSA503_0 (CYSTEINE DESULFURASE) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | ALA A 642ARG A 452HIS A 646THR A 75 | FLC A 756 (-3.0A)FLC A 756 (-3.0A)NoneFLC A 756 ( 4.4A) | 1.26A | 5db5A-1b0kA:undetectable5db5B-1b0kA:undetectable | 5db5A-1b0kA:20.085db5B-1b0kA:20.08 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5DXB_A_ESTA1000_1 (ESTROGEN RECEPTOR) |
5fdn | PHOSPHOENOLPYRUVATECARBOXYLASE 3 (Arabidopsisthaliana) | 5 / 10 | ALA A 694GLU A 697LEU A 654ARG A 145GLY A 647 | NoneNoneNoneNoneFLC A1002 (-3.3A) | 1.30A | 5dxbA-5fdnA:2.9 | 5dxbA-5fdnA:14.15 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5E5K_B_017B201_2 (HIV-1 PROTEASE) |
5wxu | 11S GLOBULIN (Wrightiatinctoria) | 5 / 12 | LEU A 162GLY A 111ILE A 112ILE A 295ILE A 160 | NoneNoneNoneFLC A 503 (-3.9A)None | 0.86A | 5e5kB-5wxuA:undetectable | 5e5kB-5wxuA:20.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EDL_A_VIBA201_1 (PUTATIVEHMP/THIAMINEPERMEASE PROTEINYKOE) |
2q7b | ACETYLTRANSFERASE,GNAT FAMILY (Streptococcusagalactiae) | 5 / 12 | TYR A 47VAL A 17ILE A 20GLN A 37SER A 66 | NoneNoneNoneFLC A 164 (-4.4A)None | 1.43A | 5edlA-2q7bA:0.0 | 5edlA-2q7bA:19.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_A_TRPA101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 5eeuA-1zb7A:undetectable5eeuB-1zb7A:undetectable | 5eeuA-1zb7A:9.285eeuB-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.20A | 5eeuD-1zb7A:undetectable5eeuE-1zb7A:undetectable | 5eeuD-1zb7A:9.285eeuE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 5eeuE-1zb7A:undetectable5eeuF-1zb7A:undetectable | 5eeuE-1zb7A:9.285eeuF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eeuG-1zb7A:undetectable5eeuH-1zb7A:undetectable | 5eeuG-1zb7A:9.285eeuH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.25A | 5eeuA-1zb7A:undetectable5eeuK-1zb7A:undetectable | 5eeuA-1zb7A:9.285eeuK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5eeuN-1zb7A:undetectable5eeuO-1zb7A:undetectable | 5eeuN-1zb7A:9.285eeuO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eeuP-1zb7A:undetectable5eeuQ-1zb7A:undetectable | 5eeuP-1zb7A:9.285eeuQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eeuR-1zb7A:undetectable5eeuS-1zb7A:undetectable | 5eeuR-1zb7A:9.285eeuS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eeuS-1zb7A:undetectable5eeuT-1zb7A:undetectable | 5eeuS-1zb7A:9.285eeuT-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eeuT-1zb7A:undetectable5eeuU-1zb7A:undetectable | 5eeuT-1zb7A:9.285eeuU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEU_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eeuU-1zb7A:undetectable5eeuV-1zb7A:undetectable | 5eeuU-1zb7A:9.285eeuV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.20A | 5eevD-1zb7A:undetectable5eevE-1zb7A:undetectable | 5eevD-1zb7A:9.285eevE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5eevE-1zb7A:undetectable5eevF-1zb7A:undetectable | 5eevE-1zb7A:9.285eevF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eevG-1zb7A:undetectable5eevH-1zb7A:undetectable | 5eevG-1zb7A:9.285eevH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.25A | 5eevA-1zb7A:undetectable5eevK-1zb7A:undetectable | 5eevA-1zb7A:9.285eevK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_L_TRPL101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | SER A 643HIS A 147HIS A 167THR A 168 | FLC A 756 (-2.8A)None O A1100 ( 3.9A)None | 0.84A | 5eevL-1b0kA:undetectable5eevV-1b0kA:undetectable | 5eevL-1b0kA:8.165eevV-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5eevN-1zb7A:undetectable5eevO-1zb7A:undetectable | 5eevN-1zb7A:9.285eevO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eevP-1zb7A:undetectable5eevQ-1zb7A:undetectable | 5eevP-1zb7A:9.285eevQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5eevR-1zb7A:undetectable5eevS-1zb7A:undetectable | 5eevR-1zb7A:9.285eevS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eevS-1zb7A:undetectable5eevT-1zb7A:undetectable | 5eevS-1zb7A:9.285eevT-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eevT-1zb7A:undetectable5eevU-1zb7A:undetectable | 5eevT-1zb7A:9.285eevU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEV_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eevU-1zb7A:undetectable5eevV-1zb7A:undetectable | 5eevU-1zb7A:9.285eevV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.20A | 5eewD-1zb7A:undetectable5eewE-1zb7A:undetectable | 5eewD-1zb7A:9.285eewE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5eewE-1zb7A:undetectable5eewF-1zb7A:undetectable | 5eewE-1zb7A:9.285eewF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eewG-1zb7A:undetectable5eewH-1zb7A:undetectable | 5eewG-1zb7A:9.285eewH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5eewA-1zb7A:undetectable5eewK-1zb7A:undetectable | 5eewA-1zb7A:9.285eewK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_L_TRPL101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | SER A 643HIS A 147HIS A 167THR A 168 | FLC A 756 (-2.8A)None O A1100 ( 3.9A)None | 0.84A | 5eewL-1b0kA:0.05eewV-1b0kA:undetectable | 5eewL-1b0kA:8.165eewV-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5eewN-1zb7A:undetectable5eewO-1zb7A:undetectable | 5eewN-1zb7A:9.285eewO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eewP-1zb7A:undetectable5eewQ-1zb7A:undetectable | 5eewP-1zb7A:9.285eewQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5eewR-1zb7A:undetectable5eewS-1zb7A:undetectable | 5eewR-1zb7A:9.285eewS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eewS-1zb7A:undetectable5eewT-1zb7A:undetectable | 5eewS-1zb7A:9.285eewT-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eewT-1zb7A:undetectable5eewU-1zb7A:undetectable | 5eewT-1zb7A:9.285eewU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEW_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eewU-1zb7A:undetectable5eewV-1zb7A:undetectable | 5eewU-1zb7A:9.285eewV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5eexD-1zb7A:undetectable5eexE-1zb7A:undetectable | 5eexD-1zb7A:9.285eexE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5eexE-1zb7A:undetectable5eexF-1zb7A:undetectable | 5eexE-1zb7A:9.285eexF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eexG-1zb7A:undetectable5eexH-1zb7A:undetectable | 5eexG-1zb7A:9.285eexH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 5eexI-1zb7A:undetectable5eexJ-1zb7A:undetectable | 5eexI-1zb7A:9.285eexJ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5eexA-1zb7A:undetectable5eexK-1zb7A:undetectable | 5eexA-1zb7A:9.285eexK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5eexN-1zb7A:undetectable5eexO-1zb7A:undetectable | 5eexN-1zb7A:9.285eexO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eexP-1zb7A:undetectable5eexQ-1zb7A:undetectable | 5eexP-1zb7A:9.285eexQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5eexQ-1zb7A:undetectable5eexR-1zb7A:undetectable | 5eexQ-1zb7A:9.285eexR-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5eexR-1zb7A:undetectable5eexS-1zb7A:undetectable | 5eexR-1zb7A:9.285eexS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eexS-1zb7A:undetectable5eexT-1zb7A:undetectable | 5eexS-1zb7A:9.285eexT-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eexT-1zb7A:undetectable5eexU-1zb7A:undetectable | 5eexT-1zb7A:9.285eexU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEX_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eexU-1zb7A:undetectable5eexV-1zb7A:undetectable | 5eexU-1zb7A:9.285eexV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5eeyD-1zb7A:undetectable5eeyE-1zb7A:undetectable | 5eeyD-1zb7A:9.285eeyE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eeyE-1zb7A:undetectable5eeyF-1zb7A:undetectable | 5eeyE-1zb7A:9.285eeyF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eeyG-1zb7A:undetectable5eeyH-1zb7A:undetectable | 5eeyG-1zb7A:9.285eeyH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 5eeyI-1zb7A:undetectable5eeyJ-1zb7A:undetectable | 5eeyI-1zb7A:9.285eeyJ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5eeyA-1zb7A:undetectable5eeyK-1zb7A:undetectable | 5eeyA-1zb7A:9.285eeyK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5eeyN-1zb7A:undetectable5eeyO-1zb7A:undetectable | 5eeyN-1zb7A:9.285eeyO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eeyP-1zb7A:undetectable5eeyQ-1zb7A:undetectable | 5eeyP-1zb7A:9.285eeyQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5eeyQ-1zb7A:undetectable5eeyR-1zb7A:undetectable | 5eeyQ-1zb7A:9.285eeyR-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5eeyR-1zb7A:undetectable5eeyS-1zb7A:undetectable | 5eeyR-1zb7A:9.285eeyS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5eeyS-1zb7A:undetectable5eeyT-1zb7A:undetectable | 5eeyS-1zb7A:9.285eeyT-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eeyT-1zb7A:undetectable5eeyU-1zb7A:undetectable | 5eeyT-1zb7A:9.285eeyU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEY_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eeyU-1zb7A:undetectable5eeyV-1zb7A:undetectable | 5eeyU-1zb7A:9.285eeyV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5eezD-1zb7A:undetectable5eezE-1zb7A:undetectable | 5eezD-1zb7A:9.285eezE-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eezE-1zb7A:undetectable5eezF-1zb7A:undetectable | 5eezE-1zb7A:9.285eezF-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5eezG-1zb7A:undetectable5eezH-1zb7A:undetectable | 5eezG-1zb7A:9.285eezH-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.24A | 5eezI-1zb7A:undetectable5eezJ-1zb7A:undetectable | 5eezI-1zb7A:9.285eezJ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5eezA-1zb7A:undetectable5eezK-1zb7A:undetectable | 5eezA-1zb7A:9.285eezK-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_L_TRPL101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | SER A 643HIS A 147HIS A 167THR A 168 | FLC A 756 (-2.8A)None O A1100 ( 3.9A)None | 0.84A | 5eezL-1b0kA:undetectable5eezV-1b0kA:undetectable | 5eezL-1b0kA:8.165eezV-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5eezN-1zb7A:undetectable5eezO-1zb7A:undetectable | 5eezN-1zb7A:9.285eezO-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eezP-1zb7A:undetectable5eezQ-1zb7A:undetectable | 5eezP-1zb7A:9.285eezQ-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5eezQ-1zb7A:undetectable5eezR-1zb7A:undetectable | 5eezQ-1zb7A:9.285eezR-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5eezR-1zb7A:undetectable5eezS-1zb7A:undetectable | 5eezR-1zb7A:9.285eezS-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5eezS-1zb7A:undetectable5eezT-1zb7A:undetectable | 5eezS-1zb7A:9.285eezT-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5eezT-1zb7A:undetectable5eezU-1zb7A:undetectable | 5eezT-1zb7A:9.285eezU-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EEZ_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5eezU-1zb7A:undetectable5eezV-1zb7A:undetectable | 5eezU-1zb7A:9.285eezV-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5ef0D-1zb7A:undetectable5ef0E-1zb7A:undetectable | 5ef0D-1zb7A:9.285ef0E-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5ef0E-1zb7A:undetectable5ef0F-1zb7A:undetectable | 5ef0E-1zb7A:9.285ef0F-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.21A | 5ef0G-1zb7A:undetectable5ef0H-1zb7A:undetectable | 5ef0G-1zb7A:9.285ef0H-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5ef0I-1zb7A:undetectable5ef0J-1zb7A:undetectable | 5ef0I-1zb7A:9.285ef0J-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5ef0A-1zb7A:undetectable5ef0K-1zb7A:undetectable | 5ef0A-1zb7A:9.285ef0K-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5ef0N-1zb7A:undetectable5ef0O-1zb7A:undetectable | 5ef0N-1zb7A:9.285ef0O-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef0P-1zb7A:undetectable5ef0Q-1zb7A:undetectable | 5ef0P-1zb7A:9.285ef0Q-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef0Q-1zb7A:undetectable5ef0R-1zb7A:undetectable | 5ef0Q-1zb7A:9.285ef0R-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5ef0R-1zb7A:undetectable5ef0S-1zb7A:undetectable | 5ef0R-1zb7A:9.285ef0S-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5ef0S-1zb7A:undetectable5ef0T-1zb7A:undetectable | 5ef0S-1zb7A:9.285ef0T-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5ef0T-1zb7A:undetectable5ef0U-1zb7A:undetectable | 5ef0T-1zb7A:9.285ef0U-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF0_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5ef0U-1zb7A:undetectable5ef0V-1zb7A:undetectable | 5ef0U-1zb7A:9.285ef0V-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5ef1D-1zb7A:undetectable5ef1E-1zb7A:undetectable | 5ef1D-1zb7A:9.285ef1E-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5ef1E-1zb7A:undetectable5ef1F-1zb7A:undetectable | 5ef1E-1zb7A:9.285ef1F-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.21A | 5ef1G-1zb7A:undetectable5ef1H-1zb7A:undetectable | 5ef1G-1zb7A:9.285ef1H-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5ef1I-1zb7A:undetectable5ef1J-1zb7A:undetectable | 5ef1I-1zb7A:9.285ef1J-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_J_TRPJ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.26A | 5ef1J-1zb7A:undetectable5ef1K-1zb7A:undetectable | 5ef1J-1zb7A:9.285ef1K-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5ef1A-1zb7A:undetectable5ef1K-1zb7A:undetectable | 5ef1A-1zb7A:9.285ef1K-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_L_TRPL101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | SER A 643HIS A 147HIS A 167THR A 168 | FLC A 756 (-2.8A)None O A1100 ( 3.9A)None | 0.84A | 5ef1L-1b0kA:undetectable5ef1V-1b0kA:undetectable | 5ef1L-1b0kA:8.165ef1V-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5ef1N-1zb7A:undetectable5ef1O-1zb7A:undetectable | 5ef1N-1zb7A:9.285ef1O-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef1P-1zb7A:undetectable5ef1Q-1zb7A:undetectable | 5ef1P-1zb7A:9.285ef1Q-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef1Q-1zb7A:undetectable5ef1R-1zb7A:undetectable | 5ef1Q-1zb7A:9.285ef1R-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5ef1R-1zb7A:undetectable5ef1S-1zb7A:undetectable | 5ef1R-1zb7A:9.285ef1S-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5ef1S-1zb7A:undetectable5ef1T-1zb7A:undetectable | 5ef1S-1zb7A:9.285ef1T-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.23A | 5ef1T-1zb7A:undetectable5ef1U-1zb7A:undetectable | 5ef1T-1zb7A:9.285ef1U-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF1_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5ef1U-1zb7A:undetectable5ef1V-1zb7A:undetectable | 5ef1U-1zb7A:9.285ef1V-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5ef2D-1zb7A:undetectable5ef2E-1zb7A:undetectable | 5ef2D-1zb7A:9.285ef2E-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5ef2E-1zb7A:undetectable5ef2F-1zb7A:undetectable | 5ef2E-1zb7A:9.285ef2F-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.21A | 5ef2G-1zb7A:undetectable5ef2H-1zb7A:undetectable | 5ef2G-1zb7A:9.285ef2H-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5ef2I-1zb7A:undetectable5ef2J-1zb7A:undetectable | 5ef2I-1zb7A:9.285ef2J-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5ef2A-1zb7A:undetectable5ef2K-1zb7A:undetectable | 5ef2A-1zb7A:9.285ef2K-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_L_TRPL101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | SER A 643HIS A 147HIS A 167THR A 168 | FLC A 756 (-2.8A)None O A1100 ( 3.9A)None | 0.84A | 5ef2L-1b0kA:undetectable5ef2V-1b0kA:undetectable | 5ef2L-1b0kA:8.165ef2V-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5ef2N-1zb7A:undetectable5ef2O-1zb7A:undetectable | 5ef2N-1zb7A:9.285ef2O-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef2P-1zb7A:undetectable5ef2Q-1zb7A:undetectable | 5ef2P-1zb7A:9.285ef2Q-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef2Q-1zb7A:undetectable5ef2R-1zb7A:undetectable | 5ef2Q-1zb7A:9.285ef2R-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5ef2R-1zb7A:undetectable5ef2S-1zb7A:undetectable | 5ef2R-1zb7A:9.285ef2S-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5ef2S-1zb7A:undetectable5ef2T-1zb7A:undetectable | 5ef2S-1zb7A:9.285ef2T-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5ef2T-1zb7A:undetectable5ef2U-1zb7A:undetectable | 5ef2T-1zb7A:9.285ef2U-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF2_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5ef2U-1zb7A:undetectable5ef2V-1zb7A:undetectable | 5ef2U-1zb7A:9.285ef2V-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_D_TRPD101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.19A | 5ef3D-1zb7A:undetectable5ef3E-1zb7A:undetectable | 5ef3D-1zb7A:9.285ef3E-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_E_TRPE101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.22A | 5ef3E-1zb7A:undetectable5ef3F-1zb7A:undetectable | 5ef3E-1zb7A:9.285ef3F-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_G_TRPG101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.21A | 5ef3G-1zb7A:undetectable5ef3H-1zb7A:undetectable | 5ef3G-1zb7A:9.285ef3H-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_I_TRPI101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 11 | THR A 271GLY A 238HIS A 237THR A 172ILE A 183 | ZN A 500 ( 4.4A)NoneNoneFLC A 501 (-4.7A)None | 1.23A | 5ef3I-1zb7A:undetectable5ef3J-1zb7A:undetectable | 5ef3I-1zb7A:9.285ef3J-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_K_TRPK101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.24A | 5ef3A-1zb7A:undetectable5ef3K-1zb7A:undetectable | 5ef3A-1zb7A:9.285ef3K-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_L_TRPL101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1b0k | PROTEIN (ACONITASE) (Susscrofa) | 4 / 8 | SER A 643HIS A 147HIS A 167THR A 168 | FLC A 756 (-2.8A)None O A1100 ( 3.9A)None | 0.84A | 5ef3L-1b0kA:0.05ef3V-1b0kA:0.0 | 5ef3L-1b0kA:8.165ef3V-1b0kA:8.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_O_TRPO101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5ef3N-1zb7A:undetectable5ef3O-1zb7A:undetectable | 5ef3N-1zb7A:9.285ef3O-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_Q_TRPQ101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.19A | 5ef3P-1zb7A:undetectable5ef3Q-1zb7A:undetectable | 5ef3P-1zb7A:9.285ef3Q-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_R_TRPR101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 9 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.20A | 5ef3Q-1zb7A:undetectable5ef3R-1zb7A:undetectable | 5ef3Q-1zb7A:9.285ef3R-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_S_TRPS101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.21A | 5ef3R-1zb7A:undetectable5ef3S-1zb7A:undetectable | 5ef3R-1zb7A:9.285ef3S-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_T_TRPT101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.17A | 5ef3S-1zb7A:undetectable5ef3T-1zb7A:undetectable | 5ef3S-1zb7A:9.285ef3T-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_U_TRPU101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.22A | 5ef3T-1zb7A:undetectable5ef3U-1zb7A:undetectable | 5ef3T-1zb7A:9.285ef3U-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EF3_V_TRPV101_0 (TRANSCRIPTIONATTENUATION PROTEINMTRB) |
1zb7 | NEUROTOXIN (Clostridiumbotulinum) | 5 / 10 | GLY A 238HIS A 237THR A 172ILE A 183THR A 271 | NoneNoneFLC A 501 (-4.7A)None ZN A 500 ( 4.4A) | 1.18A | 5ef3U-1zb7A:undetectable5ef3V-1zb7A:undetectable | 5ef3U-1zb7A:9.285ef3V-1zb7A:9.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ESL_A_1YNA701_2 (LANOSTEROL 14-ALPHADEMETHYLASE) |
4uzy | FLAGELLAR ASSOCIATEDPROTEININTRAFLAGELLARTRANSPORT PROTEINIFT52 (Chlamydomonasreinhardtii) | 4 / 5 | ALA A 410PRO A 416GLY A 325LEU B 343 | NoneFLC A1647 (-3.5A)NoneNone | 0.92A | 5eslA-4uzyA:undetectable | 5eslA-4uzyA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FSA_B_X2NB590_1 (CYP51 VARIANT1) |
2p4q | 6-PHOSPHOGLUCONATEDEHYDROGENASE,DECARBOXYLATING 1 (Saccharomycescerevisiae) | 5 / 12 | GLY A 129PHE A 394TYR A 379PHE A 371HIS A 185 | FLC A 502 ( 4.5A)NoneNoneNoneFLC A 502 (-4.5A) | 1.11A | 5fsaB-2p4qA:undetectable | 5fsaB-2p4qA:21.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FSE_C_HQEC1583_1 (UREASE SUBUNIT ALPHA) |
3fky | GLUTAMINE SYNTHETASE (Saccharomycescerevisiae) | 4 / 5 | ILE A 339GLN A 132CYH A 249GLU A 133 | NoneNoneNoneFLC A 371 (-3.2A) | 1.27A | 5fseC-3fkyA:0.0 | 5fseC-3fkyA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FUQ_A_ACTA1278_0 (NAD(P)HDEHYDROGENASE[QUINONE] 1) |
5yhp | COLD ACTIVE PROLINEIMINOPEPTIDASE (Glaciozymaantarctica) | 4 / 5 | HIS A 297SER A 111GLN A 265ILE A 136 | FLC A 402 (-3.7A)FLC A 402 (-2.5A)NoneNone | 1.43A | 5fuqA-5yhpA:2.05fuqB-5yhpA:undetectable | 5fuqA-5yhpA:20.605fuqB-5yhpA:20.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVQ_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 5fvqA-4lmvA:undetectable5fvqB-4lmvA:undetectable | 5fvqA-4lmvA:21.005fvqB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVR_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 5fvrA-4lmvA:undetectable5fvrB-4lmvA:undetectable | 5fvrA-4lmvA:21.005fvrB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVS_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 5fvsA-4lmvA:undetectable5fvsB-4lmvA:undetectable | 5fvsA-4lmvA:21.005fvsB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVT_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 5fvtA-4lmvA:undetectable5fvtB-4lmvA:undetectable | 5fvtA-4lmvA:21.005fvtB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVT_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 5fvtA-4lmvA:undetectable5fvtB-4lmvA:undetectable | 5fvtA-4lmvA:21.005fvtB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVU_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 5fvuA-4lmvA:undetectable5fvuB-4lmvA:undetectable | 5fvuA-4lmvA:21.095fvuB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVV_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.15A | 5fvvA-4lmvA:undetectable5fvvB-4lmvA:undetectable | 5fvvA-4lmvA:21.095fvvB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVW_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 5fvwA-4lmvA:undetectable5fvwB-4lmvA:undetectable | 5fvwA-4lmvA:21.095fvwB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FVX_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 5fvxA-4lmvA:undetectable5fvxB-4lmvA:undetectable | 5fvxA-4lmvA:21.095fvxB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0N_A_H4BA760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 5g0nA-4lmvA:undetectable5g0nB-4lmvA:undetectable | 5g0nA-4lmvA:21.005g0nB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5G0N_B_H4BB760_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 5g0nA-4lmvA:undetectable5g0nB-4lmvA:undetectable | 5g0nA-4lmvA:21.005g0nB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H2U_A_1N1A501_1 (PROTEIN-TYROSINEKINASE 6) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | VAL A 222ALA A 233LEU A 263THR A 283GLY A 289LEU A 343 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)TAK A1507 (-3.5A)TAK A1507 (-4.7A) | 0.71A | 5h2uA-4c02A:24.8 | 5h2uA-4c02A:28.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H2U_B_1N1B501_1 (PROTEIN-TYROSINEKINASE 6) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 7 / 12 | VAL A 222ALA A 233LEU A 263THR A 283GLY A 289LEU A 343ASP A 354 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)TAK A1507 (-3.5A)TAK A1507 (-4.7A)TAK A1507 (-3.5A) | 0.80A | 5h2uB-4c02A:25.1 | 5h2uB-4c02A:28.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5H8T_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3zh4 | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Streptococcuspneumoniae) | 5 / 12 | LEU A 371ALA A 375ILE A 282ILE A 235LEU A 268 | FLC A1419 (-4.0A)NoneNoneNoneNone | 1.10A | 5h8tA-3zh4A:undetectable | 5h8tA-3zh4A:12.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HBS_A_RTLA201_0 (RETINOL-BINDINGPROTEIN 1) |
3zh4 | UDP-N-ACETYLGLUCOSAMINE1-CARBOXYVINYLTRANSFERASE (Streptococcuspneumoniae) | 5 / 12 | LEU A 371ALA A 375ILE A 282ILE A 235LEU A 268 | FLC A1419 (-4.0A)NoneNoneNoneNone | 1.15A | 5hbsA-3zh4A:undetectable | 5hbsA-3zh4A:12.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5HI2_A_BAXA801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | ALA A 233LYS A 235LEU A 263THR A 283LEU A 319HIS A 334 | TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A)NoneNone | 0.67A | 5hi2A-4c02A:24.9 | 5hi2A-4c02A:30.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | PHE A 237VAL A 222ALA A 233LEU A 263THR A 283 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.77A | 5hieA-4c02A:24.3 | 5hieA-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_A_P06A801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.37A | 5hieA-4c02A:24.3 | 5hieA-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | PHE A 237VAL A 222ALA A 233LEU A 263THR A 283 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.78A | 5hieB-4c02A:24.2 | 5hieB-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.37A | 5hieB-4c02A:24.2 | 5hieB-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_B_P06B801_2 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
2p2w | CITRATE SYNTHASE (Thermotogamaritima) | 5 / 7 | ILE A 295GLY A 249LEU A 267PHE A 277ASP A 300 | NoneFLC A 402 ( 3.9A)NoneNoneFLC A 401 ( 3.0A) | 1.41A | 5hieB-2p2wA:undetectable | 5hieB-2p2wA:20.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_C_P06C801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | GLY A 215PHE A 237VAL A 222ALA A 233LEU A 263THR A 283 | NoneNoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.79A | 5hieC-4c02A:5.3 | 5hieC-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_C_P06C801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 6 / 12 | GLY A 215VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.47A | 5hieC-4c02A:5.3 | 5hieC-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_D_P06D801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | PHE A 237VAL A 222ALA A 233LEU A 263THR A 283 | NoneTAK A1507 (-4.7A)TAK A1507 (-3.3A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.77A | 5hieD-4c02A:24.3 | 5hieD-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HIE_D_P06D801_1 (SERINE/THREONINE-PROTEIN KINASE B-RAF) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 5 / 12 | VAL A 222ALA A 233LYS A 235LEU A 263THR A 283 | TAK A1507 (-4.7A)TAK A1507 (-3.3A)TAK A1507 ( 4.5A)FLC A1503 ( 4.5A)TAK A1507 (-3.6A) | 0.36A | 5hieD-4c02A:24.3 | 5hieD-4c02A:28.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HWA_A_GCSA301_1 (CHITOSANASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 4 / 8 | ASP A 407GLY A 185LEU A 216ASN A 220 | NoneFLC A 501 (-3.5A)NoneNone | 0.76A | 5hwaA-5x9rA:undetectable | 5hwaA-5x9rA:19.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5I3C_A_AC2A301_1 (PURINE NUCLEOSIDEPHOSPHORYLASEDEOD-TYPE) |
3mcf | DIPHOSPHOINOSITOLPOLYPHOSPHATEPHOSPHOHYDROLASE3-ALPHA (Homosapiens) | 5 / 9 | ARG A 115SER A 38ALA A 21VAL A 47GLU A 69 | FLC A 0 (-3.1A)FLC A 0 (-3.2A)NoneNoneFLC A 0 ( 4.7A) | 1.20A | 5i3cA-3mcfA:undetectable | 5i3cA-3mcfA:18.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IWU_A_ERYA404_1 (MACROLIDE2'-PHOSPHOTRANSFERASE II) |
5htk | 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE 2 (Homosapiens) | 4 / 6 | GLY A 75ASP A 189ILE A 194TYR A 197 | FLC A 601 (-3.0A)NoneNoneGOL A 606 ( 3.4A) | 0.84A | 5iwuA-5htkA:undetectable | 5iwuA-5htkA:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KPC_A_SAMA401_1 (PAVINEN-METHYLTRANSFERASE) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 4 / 5 | SER A 77ASN A 95GLN A 69ASP A 153 | NoneFLC A 424 (-3.6A)None ZN A 423 ( 2.4A) | 1.42A | 5kpcA-3d6nA:undetectable | 5kpcA-3d6nA:20.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M50_B_TA1B502_1 (TUBULIN BETA-2BCHAIN) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 5 / 12 | VAL A 410ASP A 407GLU A 409GLY A 185LEU A 216 | NoneNoneNoneFLC A 501 (-3.5A)None | 1.50A | 5m50B-5x9rA:undetectable | 5m50B-5x9rA:22.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5M5C_E_TA1E502_1 (TUBULIN BETA-2BCHAIN) |
3ie1 | RIBONUCLEASETTHA0252 (Thermusthermophilus) | 5 / 10 | VAL A 399LEU A 163ALA A 185GLY A 410LEU A 413 | NoneNoneNoneFLC A 451 ( 4.3A)None | 1.23A | 5m5cE-3ie1A:undetectable | 5m5cE-3ie1A:23.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N4T_A_BEZA507_0 (BETA-LACTAMASE VIM-2) |
1po0 | IRON(III) DICITRATETRANSPORT PROTEINFECA PRECURSOR (Escherichiacoli) | 3 / 3 | THR A 138HIS A 141ASN A 135 | FLC A 742 (-2.7A)NoneNone | 1.00A | 5n4tA-1po0A:0.0 | 5n4tA-1po0A:16.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5J_A_HAEA306_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 4 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.29A | 5n5jA-4a3wA:8.1 | 5n5jA-4a3wA:26.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N5K_A_HAEA306_1 (MACROPHAGEMETALLOELASTASE) |
4a3w | ARCHAEMETZINCIN (Archaeoglobusfulgidus) | 4 / 5 | HIS A 117GLU A 118HIS A 121HIS A 127 | ZN A1159 ( 3.2A)FLC A1161 (-2.9A) ZN A1159 ( 3.3A) ZN A1159 ( 3.2A) | 0.31A | 5n5kA-4a3wA:8.2 | 5n5kA-4a3wA:26.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5NCD_D_ACTD301_0 (PEPTIDOGLYCANN-ACETYLGLUCOSAMINEDEACETYLASE) |
5jpe | SERINE/THREONINE-PROTEIN PHOSPHATASE (Candidaalbicans) | 4 / 4 | ASP A 257HIS A 338HIS A 413HIS A 290 | FLC A 501 (-3.8A)NoneFLC A 501 (-4.0A)FLC A 501 (-3.8A) | 1.43A | 5ncdD-5jpeA:undetectable | 5ncdD-5jpeA:21.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNT_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 5untA-4lmvA:undetectable5untB-4lmvA:undetectable | 5untA-4lmvA:21.005untB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 5untA-4lmvA:undetectable5untB-4lmvA:undetectable | 5untA-4lmvA:21.005untB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UNW_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 5unwA-4lmvA:undetectable5unwB-4lmvA:undetectable | 5unwA-4lmvA:21.005unwB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO5_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 5uo5A-4lmvA:undetectable5uo5B-4lmvA:undetectable | 5uo5A-4lmvA:21.095uo5B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UO7_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 8 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 5uo7A-4lmvA:undetectable5uo7B-4lmvA:undetectable | 5uo7A-4lmvA:21.095uo7B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UUN_A_ACTA312_0 (GLUTATHIONES-TRANSFERASE-LIKEPROTEIN) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 3 / 3 | ILE A 324VAL A 277PRO A 279 | NoneFLC A 424 ( 3.8A)None | 0.65A | 5uunA-3d6nA:undetectable | 5uunA-3d6nA:22.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V4V_A_NCAA402_0 (NADPH DEHYDROGENASE3) |
3n9t | PNPC (Pseudomonasputida) | 4 / 8 | HIS A 218TYR A 194PHE A 108PRO A 107 | FE A 292 ( 3.2A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A)FLC A 293 (-3.5A) | 1.28A | 5v4vA-3n9tA:undetectable | 5v4vA-3n9tA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V4V_B_NCAB402_0 (NADPH DEHYDROGENASE3) |
3n9t | PNPC (Pseudomonasputida) | 4 / 8 | HIS A 218TYR A 194PHE A 108PRO A 107 | FE A 292 ( 3.2A)FLC A 293 ( 4.0A)FLC A 293 (-4.3A)FLC A 293 (-3.5A) | 1.26A | 5v4vB-3n9tA:undetectable | 5v4vB-3n9tA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_B_CVIB301_1 (REGULATORY PROTEINTETR) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 4 / 8 | GLY A 200ARG A 161ASP A 174ASP A 88 | NoneNoneNoneFLC A 300 (-2.8A) | 0.96A | 5vlmB-4x84A:undetectable | 5vlmB-4x84A:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VLM_F_CVIF301_1 (REGULATORY PROTEINTETR) |
4x84 | RIBOSE-5-PHOSPHATEISOMERASE A (Pseudomonasaeruginosa) | 4 / 8 | ILE A 172ARG A 161VAL A 175ASP A 88 | NoneNoneNoneFLC A 300 (-2.8A) | 1.00A | 5vlmF-4x84A:undetectable | 5vlmF-4x84A:21.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUI_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 5vuiA-4lmvA:undetectable5vuiB-4lmvA:undetectable | 5vuiA-4lmvA:21.005vuiB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUJ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.04A | 5vujA-4lmvA:undetectable5vujB-4lmvA:undetectable | 5vujA-4lmvA:21.005vujB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUL_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.07A | 5vulA-4lmvA:undetectable5vulB-4lmvA:undetectable | 5vulA-4lmvA:21.005vulB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUM_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.07A | 5vumA-4lmvA:undetectable5vumB-4lmvA:undetectable | 5vumA-4lmvA:21.005vumB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUN_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 5vunA-4lmvA:undetectable5vunB-4lmvA:undetectable | 5vunA-4lmvA:21.005vunB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUO_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 5vuoA-4lmvA:undetectable5vuoB-4lmvA:undetectable | 5vuoA-4lmvA:21.005vuoB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUP_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 5vupA-4lmvA:undetectable5vupB-4lmvA:undetectable | 5vupA-4lmvA:21.005vupB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUQ_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.07A | 5vuqA-4lmvA:undetectable5vuqB-4lmvA:undetectable | 5vuqA-4lmvA:21.005vuqB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.09A | 5vutA-4lmvA:undetectable5vutB-4lmvA:undetectable | 5vutA-4lmvA:21.005vutB-4lmvA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUV_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 5vuvA-4lmvA:undetectable5vuvB-4lmvA:undetectable | 5vuvA-4lmvA:21.095vuvB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUW_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 5vuwA-4lmvA:undetectable5vuwB-4lmvA:undetectable | 5vuwA-4lmvA:21.095vuwB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUX_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 5vuxA-4lmvA:undetectable5vuxB-4lmvA:undetectable | 5vuxA-4lmvA:21.095vuxB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUY_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.06A | 5vuyA-4lmvA:undetectable5vuyB-4lmvA:undetectable | 5vuyA-4lmvA:21.095vuyB-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV0_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 5vv0A-4lmvA:undetectable5vv0B-4lmvA:undetectable | 5vv0A-4lmvA:21.095vv0B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV1_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 6 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 5vv1A-4lmvA:undetectable5vv1B-4lmvA:undetectable | 5vv1A-4lmvA:21.095vv1B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV2_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 5vv2A-4lmvA:undetectable5vv2B-4lmvA:undetectable | 5vv2A-4lmvA:21.095vv2B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VV3_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 5vv3A-4lmvA:undetectable5vv3B-4lmvA:undetectable | 5vv3A-4lmvA:21.095vv3B-4lmvA:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WGQ_A_ESTA601_1 (ESTROGEN RECEPTOR) |
5fdn | PHOSPHOENOLPYRUVATECARBOXYLASE 3 (Arabidopsisthaliana) | 5 / 9 | ALA A 694GLU A 697LEU A 654ARG A 145GLY A 647 | NoneNoneNoneNoneFLC A1002 (-3.3A) | 1.34A | 5wgqA-5fdnA:3.7 | 5wgqA-5fdnA:6.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WM2_A_ACTA605_0 (SALICYLATE-AMPLIGASE) |
5x9r | CITRATE-SODIUMSYMPORTER (Klebsiellapneumoniae) | 3 / 3 | THR A 349THR A 217ARG A 402 | NoneNoneFLC A 501 (-3.7A) | 1.04A | 5wm2A-5x9rA:undetectable | 5wm2A-5x9rA:21.64 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XIP_C_HFGC1003_0 (PROLYL-TRNASYNTHETASE, PUTATIVE) |
5zi9 | CYTOKININ RIBOSIDE5'-MONOPHOSPHATEPHOSPHORIBOHYDROLASE (Streptomycescoelicolor) | 5 / 12 | GLU A 117THR A 83GLU A 89THR A 179GLY A 176 | NoneNoneNoneFLC A 502 ( 3.8A)FLC A 502 (-3.4A) | 1.26A | 5xipC-5zi9A:3.3 | 5xipC-5zi9A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y7P_C_CHDC401_0 (BILE SALT HYDROLASE) |
4c02 | ACTIVIN RECEPTORTYPE-1 (Homosapiens) | 4 / 8 | LEU A 337ILE A 262LEU A 489ALA A 488 | NoneNoneFLC A1505 ( 4.0A)FLC A1506 (-3.6A) | 0.69A | 5y7pC-4c02A:undetectable | 5y7pC-4c02A:22.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Y9Y_A_ACTA412_0 (UNCHARACTERIZEDPROTEIN KDOO) |
3blw | ISOCITRATEDEHYDROGENASE [NAD]SUBUNIT 1 (Saccharomycescerevisiae) | 3 / 3 | ARG A 274PHE A 136ARG A 129 | FLC A1001 (-3.4A)FLC A1001 (-4.5A)FLC A1001 (-3.4A) | 1.11A | 5y9yA-3blwA:undetectable | 5y9yA-3blwA:20.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YW0_A_ACTA409_0 (UNCHARACTERIZEDPROTEIN KDOO) |
3som | METHYLMALONICACIDURIA ANDHOMOCYSTINURIA TYPEC PROTEIN (Homosapiens) | 3 / 3 | ASP A 77PHE A 223ARG A 161 | NoneFLC A 501 (-3.9A)FLC A 501 (-2.6A) | 0.82A | 5yw0A-3somA:undetectable | 5yw0A-3somA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZRD_A_CUA607_0 (TYROSINASE) |
5fq0 | KDGF (Halomonassp.) | 3 / 3 | HIS B 48HIS B 89HIS B 50 | FLC B1114 ( 3.3A) NI B1113 ( 3.3A) NI B1113 ( 3.3A) | 0.42A | 5zrdA-5fq0B:undetectable | 5zrdA-5fq0B:11.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUR_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.12A | 6aurA-4lmvA:undetectable6aurB-4lmvA:undetectable | 6aurA-4lmvA:15.006aurB-4lmvA:15.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUS_B_H4BB803_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.12A | 6ausA-4lmvA:undetectable6ausB-4lmvA:undetectable | 6ausA-4lmvA:15.006ausB-4lmvA:15.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUT_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.13A | 6autA-4lmvA:undetectable6autB-4lmvA:undetectable | 6autA-4lmvA:15.006autB-4lmvA:15.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUX_B_H4BB802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | PHE A 7GLU A 42ARG A 29VAL A 73 | NoneNoneNoneFLC A 300 (-4.1A) | 1.10A | 6auxA-4lmvA:undetectable6auxB-4lmvA:undetectable | 6auxA-4lmvA:15.006auxB-4lmvA:15.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUY_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.09A | 6auyA-4lmvA:undetectable6auyB-4lmvA:undetectable | 6auyA-4lmvA:14.696auyB-4lmvA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AUZ_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 6auzA-4lmvA:undetectable6auzB-4lmvA:undetectable | 6auzA-4lmvA:14.696auzB-4lmvA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV1_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.04A | 6av1A-4lmvA:undetectable6av1B-4lmvA:undetectable | 6av1A-4lmvA:14.696av1B-4lmvA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV2_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 6av2A-4lmvA:undetectable6av2B-4lmvA:undetectable | 6av2A-4lmvA:14.696av2B-4lmvA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV3_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.11A | 6av3A-4lmvA:undetectable6av3B-4lmvA:undetectable | 6av3A-4lmvA:14.696av3B-4lmvA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AV4_A_H4BA802_1 (NITRIC OXIDESYNTHASE, BRAIN) |
4lmv | GLUTATHIONETRANSFERASE (Phanerochaetechrysosporium) | 4 / 7 | ARG A 29VAL A 73PHE A 7GLU A 42 | NoneFLC A 300 (-4.1A)NoneNone | 1.10A | 6av4A-4lmvA:undetectable6av4B-4lmvA:undetectable | 6av4A-4lmvA:14.696av4B-4lmvA:14.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_B_9F2B400_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.66A | 6b5yB-5ctmA:18.0 | 6b5yB-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B5Y_D_9F2D400_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.71A | 6b5yD-5ctmA:18.0 | 6b5yD-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_B_9F2B301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.55A | 6b68B-5ctmA:18.0 | 6b68B-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B68_D_9F2D400_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 5 / 12 | SER A 101SER A 149LYS A 239GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.2A)None | 0.61A | 6b68D-5ctmA:17.4 | 6b68D-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_B_9F2B301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.60A | 6b69A-5ctmA:17.96b69B-5ctmA:17.3 | 6b69A-5ctmA:13.456b69B-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B69_D_9F2D301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.61A | 6b69D-5ctmA:17.9 | 6b69D-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_B_9F2B301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.59A | 6b6aB-5ctmA:18.0 | 6b6aB-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6A_D_9F2D301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.59A | 6b6aD-5ctmA:17.8 | 6b6aD-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6C_A_9F2A301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.69A | 6b6cA-5ctmA:17.8 | 6b6cA-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6D_A_9F2A302_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.46A | 6b6dA-5ctmA:17.7 | 6b6dA-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6E_A_9F2A302_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 6 / 12 | SER A 101SER A 149LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.67A | 6b6eA-5ctmA:18.0 | 6b6eA-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6B6F_A_9F2A301_1 (BETA-LACTAMASE) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 5 / 12 | SER A 101LYS A 239THR A 240GLY A 241GLY A 243 | KCX A 104 (-2.2A)FLC A 301 (-3.0A)FLC A 301 (-3.8A)FLC A 301 (-3.2A)None | 0.43A | 6b6fA-5ctmA:17.6 | 6b6fA-5ctmA:13.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BTX_A_EDTA503_0 (SOLUTE CARRIERFAMILY 39(IRON-REGULATEDTRANSPORTER)) |
3d6n | ASPARTATECARBAMOYLTRANSFERASE (Aquifexaeolicus) | 4 / 7 | SER B 45HIS B 126GLY B 120ARG B 282 | FLC B 292 ( 4.5A)FLC B 292 (-4.0A)NoneNone | 1.04A | 6btxA-3d6nB:undetectable | 6btxA-3d6nB:22.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6C79_A_CE3A301_1 (BETA-LACTAMASETOHO-1) |
5ctm | BETA-LACTAMASE (Bacilluspumilus) | 5 / 12 | SER A 149LYS A 239GLY A 241SER A 242GLY A 243 | FLC A 301 (-2.5A)FLC A 301 (-3.0A)FLC A 301 (-3.2A)FLC A 301 (-2.8A)None | 0.67A | 6c79A-5ctmA:18.9 | 6c79A-5ctmA:14.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DCH_A_ACTA401_0 (SCOE PROTEIN) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 4 / 5 | HIS A 34ASP A 161HIS A 58ARG A 158 | FE A 202 ( 3.3A) FE A 202 ( 2.5A) FE A 202 (-3.3A)FLC A 203 (-3.0A) | 1.50A | 6dchA-4n6wA:undetectable | 6dchA-4n6wA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6DCH_A_ACTA401_0 (SCOE PROTEIN) |
4n6w | PREDICTED HDPHOSPHOHYDROLASEPHNZ (unculturedbacteriumHF130_AEPn_1) | 4 / 5 | THR A 129HIS A 80ASP A 59HIS A 104 | FLC A 203 (-3.2A) FE A 201 ( 3.4A) FE A 202 (-2.6A) FE A 201 ( 3.4A) | 0.94A | 6dchA-4n6wA:undetectable | 6dchA-4n6wA:21.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EXI_C_ADNC502_0 (ADENOSYLHOMOCYSTEINASE) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 12 | THR A 124ASP A 305HIS A 180ASN A 95HIS A 63 | NoneFLC A 424 ( 2.7A)FLC A 424 (-4.0A)FLC A 424 (-3.6A) ZN A 423 ( 3.4A) | 1.27A | 6exiC-3d6nA:undetectable | 6exiC-3d6nA:15.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6EXI_D_ADND502_0 (ADENOSYLHOMOCYSTEINASE) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 12 | THR A 124ASP A 305HIS A 180ASN A 95HIS A 63 | NoneFLC A 424 ( 2.7A)FLC A 424 (-4.0A)FLC A 424 (-3.6A) ZN A 423 ( 3.4A) | 1.22A | 6exiD-3d6nA:undetectable | 6exiD-3d6nA:15.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GNG_B_QPSB601_1 (-) |
3d6n | DIHYDROOROTASE (Aquifexaeolicus) | 5 / 12 | THR A 96THR A 126HIS A 306PRO A 176GLY A 323 | NoneNoneNoneNoneFLC A 424 (-3.2A) | 1.30A | 6gngB-3d6nA:undetectable | 6gngB-3d6nA:20.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_A_TKTA508_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
5z7h | LYSR FAMILYTRANSCRIPTIONALREGULATOR (Staphylococcusaureus) | 4 / 8 | ASP A 185ILE A 187ARG A 256TYR A 204 | NoneNoneFLC A 301 (-3.6A)None | 1.25A | 6hisA-5z7hA:undetectable6hisB-5z7hA:undetectable | 6hisA-5z7hA:22.996hisB-5z7hA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_B_TKTB508_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
5z7h | LYSR FAMILYTRANSCRIPTIONALREGULATOR (Staphylococcusaureus) | 4 / 8 | ASP A 185ILE A 187ARG A 256TYR A 204 | NoneNoneFLC A 301 (-3.6A)None | 1.25A | 6hisB-5z7hA:undetectable6hisC-5z7hA:undetectable | 6hisB-5z7hA:22.996hisC-5z7hA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HIS_D_TKTD501_0 (5-HYDROXYTRYPTAMINERECEPTOR 3A) |
5z7h | LYSR FAMILYTRANSCRIPTIONALREGULATOR (Staphylococcusaureus) | 4 / 8 | ASP A 185ILE A 187ARG A 256TYR A 204 | NoneNoneFLC A 301 (-3.6A)None | 1.25A | 6hisD-5z7hA:undetectable6hisE-5z7hA:undetectable | 6hisD-5z7hA:22.996hisE-5z7hA:22.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6HLP_A_GAWA1501_0 (SUBSTANCE-PRECEPTOR,SUBSTANCE-PRECEPTOR) |
5ltg | AUTOPHAGY-RELATEDPROTEIN 18 (Ogataeaangusta) | 5 / 12 | ILE A 270THR A 239ILE A 247HIS A 221PRO A 179 | NoneNoneNoneFLC A 602 (-3.8A)None | 1.07A | 6hlpA-5ltgA:undetectable | 6hlpA-5ltgA:22.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN4_A_AM2A301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
5aga | DNA POLYMERASE THETA (Homosapiens) | 4 / 8 | HIS A 365ARG A 438HIS A 338GLU A 383 | FLC A1893 ( 4.5A)FLC A1893 ( 4.9A)NoneNone | 1.18A | 6mn4A-5agaA:undetectable | 6mn4A-5agaA:15.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN4_B_AM2B301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
5aga | DNA POLYMERASE THETA (Homosapiens) | 4 / 8 | HIS A 365ARG A 438HIS A 338GLU A 383 | FLC A1893 ( 4.5A)FLC A1893 ( 4.9A)NoneNone | 1.24A | 6mn4B-5agaA:undetectable | 6mn4B-5agaA:15.66 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MN4_F_AM2F301_0 (AMINOGLYCOSIDEN(3)-ACETYLTRANSFERASE, AAC(3)-IVA) |
5z7h | LYSR FAMILYTRANSCRIPTIONALREGULATOR (Staphylococcusaureus) | 4 / 7 | ARG A 256HIS A 162ASP A 185GLU A 130 | FLC A 301 (-3.6A)NoneNoneFLC A 301 (-3.6A) | 1.29A | 6mn4F-5z7hA:undetectable | 6mn4F-5z7hA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6QGB_D_BEZD701_0 (MONO(2-HYDROXYETHYL)TEREPHTHALATEHYDROLASE) |
5hvf | CARBOXYPEPTIDASE B2 (Homosapiens) | 5 / 10 | GLY A 347SER A 286ALA A 343ARG A 235HIS A 288 | NoneNoneFLC A 509 (-3.2A)FLC A 509 (-2.8A) ZN A 508 (-3.1A) | 1.47A | 6qgbD-5hvfA:3.0 | 6qgbD-5hvfA:19.97 |